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ABSTRACT 
 
 
 
Diffusion-weighted and dynamic susceptibility contrast magnetic resonance imaging 
(DWI and DSC MRI, respectively) are used worldwide to evaluate abnormal water 
diffusion and cerebral blood circulation in clinical settings, especially in the imaging of 
acute stroke. However, diffusion and perfusion parameters of healthy populations have 
not been extensively studied to date.  These parameters are essential for the more 
quantitative comparison of disease states with healthy brains. In addition, the feasibility 
of DWI and DSC MRI to detect changes induced by high-grade carotid stenosis (CS), 
carotid endarterectomy (CEA), and leukoaraiosis (LA), has received little attention. 
Accordingly, the purpose of this thesis was to determine the normal absolute values of 
diffusion and perfusion parameters, and their dependence on age, gender, and brain 
hemisphere, to assess the influence of CS, CEA, and LA on these parameters, and to 
identify differences between asymptomatic and symptomatic CS patients (ACS and SCS, 
respectively). 
Eighty healthy subjects (40 male, 40 female) aged 22 to 85 years, 10 patients with 
acute ischemic stroke, 46 patients with unilateral high-grade CS, and 85 subjects with LA 
were imaged with DWI and/or DSC MRI, and with conventional images at 1.5 Tesla. 
Healthy subjects and patients with LA were imaged in one imaging session each. CS 
patients were imaged three times: preoperatively, and 3 and 100 days after CEA, and 
ischemic stroke patients five times: less than 6 hours, 24 hours, one week, one month, 
and 3 months after the insult. Maps of the average apparent diffusion coefficient 
(ADCav), cerebral blood volume (CBV), cerebral blood flow (CBF), and mean transit time 
(MTT) were created. Several regions of the brain and the lesions of ischemic stroke and 
LA were selected for the analyses. 
Generally, the diffusion and perfusion parameters in the selected regions of the 
healthy brain did not differ with age, gender, or brain hemisphere. By contrast, the 
ADCav values, CBF, and MTT of CS patients were different between hemispheres before 
CEA. However, postoperatively and in the chronic phase, no such differences were 
detected in these patients. The perfusion parameters of ACS and SCS patients showed 
slightly different patterns before and after CEA, but no differences in the ADCav values 
between these two groups were found. The ADCav values of the leukoaraiotic regions or 
the normal-appearing white matter (WM) and the severity of LA correlated significantly; 
the more severe the LA, the higher the ADCav values. The leukoaraiotic regions, the 
normal-appearing WM, and ischemic stroke in its various phases could be distinguished 
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from each other based solely on analysis of ADCav values. An exception was ischemic 
stroke at one month, when the ADCav values overlapped with those of LA. 
In conclusion, measurements of brain diffusion and perfusion with DWI and 
DSC MRI can detect and distinguish several diseases at various stages. Normal ADCav 
values and perfusion parameters lie within a narrow range in healthy individuals, 
regardless of age and gender. In CS patients, the term ‘preleukoaraiosis’ was introduced 
to define the ipsilateral normal-appearing WM with high ADCav values, which were partly 
reversible by CEA. Cerebral perfusion measurements with DSC MRI disclosed typical 
patterns in ACS and SCS patients, but the ADCav values appeared not to be useful in 
differentiating these patient groups. The regions of LA and the normal-appearing WM of 
the subjects with LA showed characteristic changes in the ADCav values, and DWI could 
be used to differentiate acute and chronic ischemic stroke lesions from LA. DWI and 
DSC MRI have become widely used MRI sequences in clinical settings since they are 
fairly easy to use and they provide additional information to the conventional MRI. 
However, the quantitative analysis of the ADCav values or perfusion parameters requires 
expertise and accuracy. 
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ABBREVIATIONS 
 
 
 
ACS   asymptomatic carotid stenosis 
AD   Alzheimer’s disease  
ADC   apparent diffusion coefficient 
ADCav   average apparent diffusion coefficient 
AIF   arterial input function 
CBF   cerebral blood flow 
CBV   cerebral blood volume 
CEA   carotid endarterectomy  
CNS   central nervous system 
CS   carotid stenosis  
CSF   cerebrospinal fluid 
CT   computed tomography 
DSC MRI  dynamic susceptibility contrast magnetic resonance imaging 
DWI   diffusion-weighted magnetic resonance imaging 
ECA   external carotid artery 
EPI   echo-planar imaging 
FOV   field of view 
Gd-DTPA  gadolinium diethylenetriaminepenta-acetic acid 
GE   gradient-echo 
GM   gray matter  
HI   hyperintensity 
ICA   internal carotid artery 
LA   leukoaraiosis 
MCA   middle cerebral artery 
MRI   magnetic resonance imaging 
MS   multiple sclerosis 
MTT   mean transit time, the CBV:CBF ratio 
PET   positron emission tomography 
PI   perfusion magnetic resonance imaging 
PVH   periventricular hyperintensity 
RF   radiofrequency 
ROI   region of interest 
rtPA   recombinant tissue plasminogen activator 
SCS   symptomatic carotid stenosis 
SD   standard deviation 
SE   spin-echo 
SPECT   single photon emission computed tomography 
SVD   singular value decomposition  
T   Tesla 
TE   echo time 
TIA   transient ischemic attack 
TR   repetition time 
WM   white matter 
WsR   watershed regions 
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INTRODUCTION 
 
 
 
Ischemic stroke is the third leading cause of death, with 4.5 million deaths a year, and the 
leading cause of disability worldwide. Its economic burden is tremendous, among the 
highest of all diseases, and the human burden to patients and their relatives is 
immeasurable. Every year, 12,000 people in Finland (Fogelholm et al., 1997) and 500,000 
in USA suffer strokes (Bonita, 1992). Despite developments in prevention, diagnosis, 
therapy, rehabilitation, awareness, and services, ischemic stroke continues to be a major 
public health problem. Therefore, management in the hyperacute phase, before the brain 
tissue-at-risk evolves into infarction, is imperative. Acute and rehabilitation care of stroke 
patients in specialized stroke units and secondary prevention including revascularizing 
therapies are also important, both in improving prognosis and in reducing economic 
burden. 
One of the major risk factors for ischemic stroke, and thus an important factor in 
the prevention of recurrent strokes, is tight carotid stenosis (CS), as it may lead to misery 
perfusion (Baron et al., 1981; Klijn et al., 1997), artery-to-artery embolism in the brain, 
and brain infarction. Carotid endarterectomy (CEA) improves the long-term survival and 
outcome of patients with symptomatic CS (SCS) (North American Symptomatic Carotid 
Endarterectomy Trial, 1991), but is less beneficial in asymptomatic CS (ASC) (Chambers 
et al., 2002). 
Leukoaraiosis (LA), another risk factor for ischemic stroke (Inzitari et al., 1997), 
may lead to cognitive decline and other disabling neurological symptoms. The term LA 
refers to bilateral and either patchy or diffuse areas of hypodensity in the cerebral white 
matter (WM) on computed tomography (CT) or hyperintensity on T2-weighted magnetic 
resonance imaging (MRI) (Hachinski et al., 1987). Its main causes are thought to be 
chronic cerebral ischemia and hypoperfusion, but the general pathogenesis and its clinical 
significance are still incompletely understood (Pantoni and Garcia, 1995; 1997). 
Diffusion-weighted magnetic resonance imaging (DWI) reveals ischemic regions 
in the brain immediately upon an acute stroke patient being submitted for imaging studies 
(Baird and Warach, 1998; Gonzalez et al., 1999). It has become an essential part of the 
imaging of hyperacute stroke patients, and its utility has also been investigated in several 
other brain diseases (Schaefer et al., 2000). It is thought to provide neuropathological 
information on the mechanisms of LA in vivo (Okada et al., 1999) and to detect minor 
and silent infarctions after CEA (Müller et al., 2000; Feiwell et al., 2001; Jaeger et al., 
2002). DWI is based on the random translational movement of water molecules in 
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biological media (diffusion). The net diffusion in biological media is referred to as the 
apparent diffusion coefficient (ADC) (Le Bihan et al., 1986). 
Perfusion imaging (PI) with dynamic susceptibility contrast magnetic resonance 
imaging (DSC MRI) has also shown promise in assessing various aspects of cerebral 
hemodynamics in ischemic stroke (Barber et al., 1998) and in other brain diseases (Cha et 
al., 2002). It is performed by combining the simultaneous use of a paramagnetic contrast 
medium and rapid collection of the MR signal during the passage of the contrast medium 
bolus through the brain (Villringer et al., 1988). The acquired data sets contain 
information about cerebral perfusion in the form of cerebral blood volume (CBV) 
(Belliveau et al., 1990; Rosen et al., 1991), cerebral blood flow (CBF) (Østergaard et al., 
1996a; Østergaard et al., 1996b), and the contrast medium mean transit time (MTT), the 
CBV:CBF ratio (Meier and Zierler, 1954; Stewart, 1984). 
Since DWI and DSC MRI are increasingly used to determine abnormal and 
pathologic water diffusion and cerebral blood circulation, respectively, a comprehensive 
study assessing diffusion and perfusion parameters in a representative healthy population 
is essential for the more quantitative comparison of disease states with healthy brains. In 
addition, the feasibility of DWI and DSC MRI to detect changes in diffusion and brain 
perfusion induced by CS, CEA, and LA has previously received too little attention. 
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REVIEW OF THE LITERATURE 
 
 
 
HEALTHY BRAIN 
 
The central nervous system (CNS) consists of the cerebrum, cerebellum, brain stem, and 
spinal cord. The cerebrum is divided into four lobes in both hemispheres, the frontal, 
temporal, parietal, and occipital lobes, each of which consist of a cerebral cortex with 
neurons (gray matter, GM) and WM with axons (Netter, 1991). The WM forms fibers 
and tracts from the cerebrum to the brain stem and spinal cord (Fitzek et al., 2001). The 
cerebral cortex has a higher water content and a substantially higher blood flow than the 
WM (de Groot and Chusid, 1991). Inside the brain is the ventricular system, which 
contains cerebrospinal fluid (CSF) that is formed in the choroid plexuses of the ventricles 
and drains through the arachnoid granules into the venous system (Netter, 1991). 
The brain receives its blood supply from four main arteries, two common carotid 
arteries and two vertebral arteries. Carotid arteries are divided into internal (ICA) and 
external carotid arteries (ECA), the former of which is mainly responsible for circulation 
in the anterior parts of the brain. The main branches of ICA are the anterior (ACA) and 
middle cerebral arteries (MCA), supplying the frontal lobes and parts of the parietal and 
temporal lobes of the brain. The basal ganglia and thalamus are also partly supplied by 
these arteries and their branches. Vertebral arteries unite to form the basilar artery, which 
sends two posterior cerebral arteries (PCA) supplying the posterior parts of the brain, 
brain stem, and cerebellum. Branches of the PCA also supply the occipital lobes and the 
posterior parts of the temporal lobes (Tatu et al., 1996; 1998). The blood drainage occurs 
via the cerebral venous system. This unites the small venules to the large venous sinuses 
of the subarachnoidal space; the largest of these are the superior sagittal sinus, cavernous 
sinus, straight sinus, sigmoid sinus, transverse sinus, and the confluence of the sinuses. 
Finally, the sinuses drain into two internal jugular veins, which drain into the subclavian 
vein (Netter, 1991). 
Fortunately, additional branches of collateral arteries supply the territories of the 
main arteries discussed above. The collateral arteries are important in the survival of brain 
tissue when blood supply is diminished in the region of a main artery either acutely due to 
thromboembolism of the artery or chronicly due to tight CS. As the GM receives 
leptomeningeal collateral supply, it survives better than the WM in chronic ischemic 
disturbances such as CS. The thalamus receives lenticulostriate branches from the MCA, 
anterior choroidal branches from the ICA, and posterior choroidal branches from the 
PCA. Generally, the collateral supply is highly variable between humans, explaining the 
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different sizes of brain infarcts sustained after occlusion of the feeding artery, which can 
jeopardize the patient’s life (Netter, 1991; Tatu et al, 1996; 1998). 
CBF is approximated to be 45-55 mL/100 g/min (Lassen, 1985). In the GM, it is 
about 80 mL/100 g/min, and in the WM 20 mL/100 g/min. In other parts of the brain, 
the blood flow depends of the amount of GM and WM and their distribution. 
 
 
AGING 
 
With age, neuronal cell loss occurs in many regions of the brain, but this change is not a 
universal phenomenon. The pattern of cell loss in healthy people is also different from 
that observed in such diseases as Alzheimer’s disease (AD). As neuroplasticity can be 
detected in the normal aging brain, it may, at least partly, compensate the age-related 
neuronal loss. The average neuron and water content of the brain, i.e. the average brain 
weight, declines with age, resulting in sulcal widening and ventricular enlargement. 
However, a wide variation exists among subjects. The intracellular pigments lipofuscin 
and neuromelanin accumulate in several regions of the brain, and even the typical AD-
change, the appearance of extracellular amyloid deposits, may occur in the normal aging 
brain. In neurotransmitter systems, the effect of age is not fully understood. Cholinergic, 
adrenergic, serotonergic, and dopaminergic neurotransmitters seem to decrease with age, 
but the effect of diseases on the levels of these neurotransmitters may have interfered 
with the results for healthy people in previous studies. Atherosclerotic changes, an 
increase in connective tissue, and the thickening of intima cause the blood vessels to 
become more rigid, elongated, and tortuous with age. Expansion of perivascular spaces 
(Virchow Robin space), the formation of lacunae, and changes in the WM (LA) are also 
frequent findings in elderly people (Mrak et al., 1997; Hamill and Pilgrim, 2000). 
In addition to autopsy studies, various imaging methods have been used to 
examine age-related changes in the human brain. The findings have been variable, from a 
clear correlation between age and changes in cerebral anatomy and physiology to no 
correlation at all. Generally, though, the WM lesions, LA, and amount of CSF have been 
found to increase, the cortical and deep GM to remain fairly constant, and the brain 
surface area and amount of WM to decline with age (Agartz et al., 1992; Chang et al., 
1996; Salonen et al., 1997; Silver et al., 1997; Guttmann et al., 1998). All of these changes 
may alter the results of imaging studies (Agartz et al., 1991; Breger et al., 1991; Bakshi et 
al., 2000), supporting the need for using age-matched controls in studies of brain 
diseases.
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GENDER 
 
The search for gender-related differences in cerebral anatomy and physiology has been 
extensive, with negligible or highly variable results. The findings of some studies of small 
differences in the amounts of GM, WM, and CSF, and women having more GM and less 
WM and CSF (Gur et al., 1999) or higher fractional anisotropy in WM (Szeszko et al., 
2003) than men, have not received support from other reports (Agartz et al, 1992; Silver 
et al, 1997). Nevertheless, the use of gender-matched controls in addition to age-matched 
ones is recommended for more reliable comparison of disease states and normal brains. 
 
 
ISCHEMIC STROKE 
 
EPIDEMIOLOGY 
 
Each year about 12,000 people suffer a stroke in Finland, and about 5,000 of them die 
either acutely or during the first year after the insult (Fogelholm et al, 1997). Stroke is the 
third leading cause of death in Finland and in most other industrialized countries and is 
the leading cause of disability. The economic burden to society due to hospitalization and 
long-term disability is tremendous. Furthermore, one-third of strokes occur in working-
aged people, being a more common cause of early retirement in Finland than ischemic 
heart disease. Stroke is defined as an abrupt focal or global neurological syndrome caused 
by ischemia or hemorrhage. By definition, these symptoms must continue for more than 
24 hours or result in death to qualify for the diagnosis of stroke. More than 80% of all 
strokes are ischemic, and the remainder is either intracerebral or subarachnoid 
hemorrhages. In the following paragraphs, the term stroke refers solely to ischemic 
stroke; the risk factors, pathophysiology, clinical aspects, and management of 
intracerebral and subarachnoid hemorrhages will not be discussed. 
Risk factors for ischemic stroke are well-defined and overlap those of ischemic 
heart disease. While many of these factors are modifiable, others, like age and gender, are 
not. Hypertension is the most important modifiable risk factor, followed by smoking and 
hyperlipidemia. Patients with heart disease (chronic atrial fibrillation, myocardial 
infarction, valvular heart disease, or congestive heart failure) (Takahashi et al., 2002), CS, 
transient ischemic attacks (TIA), silent brain infarcts (Jørgensen et al., 1994), diabetes, 
obesity, physical inactivity, recent infection, excessive alcohol intake, disturbances in 
hemocoagulation, elevation of plasma fibrinogen, antiphospholipid antibodies, and 
anticardiolipin antibodies are known to have an increased risk for stroke. The postpartum 
phase of pregnancy, vasculitis, collagenoses, CADASIL (cerebral autosomal dominant 
 15 
arteriopathy with subcortical infarcts and leukoencephalography), and homocysteinuria 
also increase the risk. The roles of elevated plasma homocysteine, oral contraceptives, 
and hormone-replacement therapy after menopause remain obscure. Most modifiable 
risk factors express themselves by accelerating atherosclerosis. Non-modifiable risk 
factors, such as older age, male sex, family history, and genetics, do not themselves cause 
atherosclerosis, but increase risk all the same (Biller and Love, 2000; Bogousslavsky et al., 
2000). 
 
 
PATHOPHYSIOLOGY 
 
Acute focal or diffuse cerebral ischemia initiates a cascade of complex biochemical 
events. Cerebral ischemia is caused by the interruption of CBF to the microcirculation, 
after which glucose and oxygen transport diminishes. Impairment of brain energy 
metabolism follows, leading to loss of aerobic glycolysis, and further, to intracellular 
accumulation of sodium and calcium ions, release of excitotoxic neurotransmitters, 
elevation of lactate levels with local acidosis, free radical production, cell swelling, 
overactivation of lipases and proteases, and finally, to cell death. Many affected neurons 
undergo apoptosis after brain ischemia, and ischemic brain injury is exacerbated by 
leukocyte infiltration and development of brain edema (Dirnagl et al., 1999). 
Interruption of CBF causes suppression of electrical activity within seconds and 
inhibition of synaptic excitability within minutes, followed by inhibition of electrical 
excitability and then cell death. When CBF is focally decreased below 18 mL/100 g/min, 
the brain tissue reaches a threshold of electrical failure, and when flow is decreased below 
8 mL/100 g/min, the threshold of membrane failure is approached and cell death may 
occur. The region between these two thresholds marks the upper and lower limits of the 
ischemic penumbra, the area of poor perfusion, in which the neurons are functionally 
silent but structurally intact and potentially salvageable with hyperacute management (see 
thrombolysis below) (Astrup et al., 1981). The region below the lower threshold is called 
the ischemic core, with the occurrence of irreversible cell death, i.e. brain infarct 
(Hossmann, 1994). 
In autopsy studies, the changes induced by ischemic stroke can be seen clearly six 
hours after the insult. Initially, the neurons swell, then they shrink and become 
hyperchromatic and pyknotic. Chromatolysis appears, the nuclei become eccentric, and 
the surrounding astrocytes swell and fragmentate. In focal blood vessels, the endothelial 
cells swell and the neutrophils begin to infiltrate the ischemic lesion. Within 48 hours, the 
microglia proliferate, ingest the products of the neuronal and astrocyte breakdown, and 
form macrophages. The process of neovascularity with the proliferation of capillaries 
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begins. The ischemic core is gradually reabsorbed, and a cavity of glial and fibrovascular 
elements forms. In large ischemic lesions, the cavity finally consists of three different 
zones: an inner area of coagulative necrosis, a medial zone of vacuolated neutrophils, 
leukocytic infiltrates, swollen axons, and thickened capillaries, and an outer zone of 
hyperplastic astrocytes and variable changes in nuclear staining (Biller and Love, 2000). 
 
 
CLINICAL ASPECTS 
 
Stroke manifests clinically with a wide variety of symptoms, depending on the size and 
location of the lesion. A lesion in the carotid territory (anterior circulation) presents with 
contralateral hemiparesis, hemianesthesia, dysphasia or hemineglect depending on the 
side of the lesion, conjugate eye deviation to the side of the ischemic lesion in large 
infarcts, and/or homonymous hemianopia. Stroke in the vertebrobasilar territory 
(posterior circulation) is associated with hemianopia, cortical blindness, vertigo, nausea, 
ataxia, nystagmus, gaze palsies, dysarthria, and a variety of other symptoms caused by 
lesions in the nuclei of cranial nerves. In addition to symptomatic lesions, asymptomatic 
lesions are fairly common, especially among older subjects. 
The classification of etiology of the ischemic stroke has been done in several ways 
in the literature. One of the most useful and reliable is the TOAST (the Trial of Org 
10172 in Acute Stroke Treatment) criterion (Adams et al., 1993; Gordon et al., 1993), 
which includes five different categories of likely etiology. These are stroke due to 1) large-
artery atherosclerosis, 2) cardioembolism, or 3) small-vessel occlusion, 4) stroke of other 
determined etiology, such as carotid dissections, and 5) stroke of undetermined etiology. 
The classification and search for the etiology underlying ischemic stroke are important, as 
the etiology affects outcome, management, and secondary prevention of stroke. 
CT has been used for the diagnosis of stroke for almost three decades and is still 
the method of choice in most centers. It is widely available and inexpensive and has a 
good sensitivity in detecting fresh blood, thus differentiating ischemic lesions from 
hemorrhagic ones. However, increasingly available worldwide, MRI offers an even more 
accurate method for the diagnosis of acute stroke. The more accurate diagnosis allows for 
better management, making MRI a very attractive alternative (Shuaib et al., 1992). 
Additionally, the newer MRI techniques, DWI and PI, have created a whole new 
perspective to the diagnosis of hyperacute stroke (discussed below). 
 17 
MANAGEMENT 
 
Since acute stroke is a medical emergency, management should be initiated before 
hospital admission by paramedics (Kaste et al., 2000). Unfortunately, one of the leading 
causes of failure in proper management is the late arrival of the patient to the hospital. 
Therefore, such informative procedures as campaigns directed at the public about 
symptoms and signs of stroke are important alongside the continuing education of 
paramedics (Kaste et al, 2000). General management of acute stroke includes monitoring 
and supporting the cardiorespiratory functions, maintaining glucose, fluid, and electrolyte 
balance, treatment of fever, and prevention and treatment of infections and seizures. 
While blood pressure is frequently elevated, it should not be treated too aggressively, 
since low blood pressure may worsen the cerebral perfusion, leading to worse outcome. 
Prophylaxis of deep venous thrombosis is recommended. Depression and other related 
medical problems should be treated where appropriate. Rehabilitation begins at the acute 
stroke unit and continues after discharge (Hacke et al., 2000; Kaste et al, 2000). 
 
 
THROMBOLYSIS 
 
Despite the numerous compounds studied for neuroprotective therapy of acute stroke 
over the past two decades, none has thus far proven effective. The only effective 
treatment for clinical use is thrombolytic therapy with recombinant tissue plasminogen 
activator (rtPA). It accelerates fibrinolysis of the thrombus within the occluded artery, 
and, by recanalization of the occluded artery, helps restore blood flow to the ischemic 
region. Thrombolytic treatment leads to a favorable outcome when given to a patient 
fulfilling the criteria. These criteria include an ischemic stroke with the onset of 
symptoms occurring less than three hours earlier, a CT lesion not exceeding one-third of 
the MCA region, and therapy being initiated within three hours of stroke onset. The 
exclusion criteria include rapidly improving neurological signs, seizure, intracranial 
hemorrhage, hypoglycemia, hyperglycemia, any recent severe bleeding, recent myocardial 
infarction, recent head injury, earlier intracerebral or subarachnoidal hemorrhage, use of 
anticoagulants, any bleeding disorders, major surgery within the past two weeks, and high 
blood pressure (Hacke et al, 2000). The time window for thrombolytic treatment is 
generally accepted to be three hours after the onset of symptoms. However, a pooled 
analysis of ATLANTIS (Clark et al., 1999), ECASS (Hacke et al., 1995), and NINDS 
rtPA (The National Institute of Neurological Disorders and Stroke rt-PA, 1995) trials 
suggests that the time window may be longer (Kaste, 2003). In some centers, 
thrombolytic treatment has been successfully administered to patients with diffusion-
perfusion mismatch even four hours after insult (Röther et al., 2002; Schellinger et al., 
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2003) (see below). In such cases, it is essential that a clear demarcation of the irreversibly 
damaged ischemic core and the ischemic but still viable and thus salvageable tissue-at-
risk-of-infarction is seen on DWI combined with PI and MRA or alternatively on CT 
combined with CT angiography and CT source image analysis (Schellinger et al, 2003). 
 
 
PREVENTION OF RECURRENCE OF STROKE 
 
After an initial stroke, the preventive methods for recurrent strokes become even more 
important. Prevention can be divided into three categories, all of which are equally 
important, but with their relative importance differing between individual patients. These 
categories are antithrombotic therapy, risk factor management, and surgical management 
(CEA or carotid stenting). Antithrombotic agents lay the foundation for stroke 
prevention. The use of low-dose aspirin for stroke prevention is recommended (Barnett 
et al., 1996). This may be combined with dipyridamole for a possible additive effect, and 
multicenter studies for combining aspirin with clopidogrel are underway. Warfarin is 
indicated in stroke patients with atrial fibrillation and in some other specific subgroups of 
stroke patients, but may be replaced in the future by new drugs. The management of risk 
factors is the key to successful stroke prevention and must be planned carefully according 
to current medical knowledge (Bogousslavsky et al, 2000). Hypertension, hyperlipidemia, 
diabetes, various heart diseases, and possible hematologic diseases should be treated 
aggressively after the acute phase. The patient should be motivated to give up smoking 
and excessive consumption of alcohol, salt, and fat, and to increase physical activity and 
lose weight. Surgical management includes CEA, carotid stenting, and some experimental 
interventions. In the following paragraphs, the background and the basic concepts 
underpinning CEA are discussed. 
 
 
CAROTID STENOSIS AND ENDARTERECTOMY 
 
EPIDEMIOLOGY 
 
One of the most common causes of ischemic stroke is artery-to-artery embolism, from 
tight CS to brain arteries. Approximately 15% of all strokes is caused by SCS. In addition 
to SCS, ACS is prevalent in the general population, especially in the elderly. However, 
when compared with SCS, ACS is associated with a relatively low risk for stroke. 
Risk factors for CS overlap those of general atheroclerosis. Hypertension, 
hyperlipidemia, diabetes, infections, age, obesity, smoking, excessive alcohol intake, and 
physical inactivity all increase the risk for atherosclerotic changes in carotid arteries. Risk 
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factors should be treated rigorously for decreasing the risk for stroke. However, 
treatment of hypertension in very tight CS or occlusion should not be too aggressive due 
to increased risk for cerebral ischemia induction (Biller and Love, 2000). 
 
 
PATHOPHYSIOLOGICAL AND CLINICAL ASPECTS 
 
Tight CS and occlusion may compromise cerebral hemodynamics. While the failure in 
hemodynamics has traditionally been associated with the symptomatic status of CS, its 
role is still controversial (Klijn et al, 1997) and far less important than embolic seeding 
from CS. The degree of CS correlates poorly with the perfusion pressure of the brain, 
and many studies have been unable to detect any significant hemodynamic abnormality in 
the majority of patients with high-grade CS (Powers et al., 1987; Powers, 1991; 
Nighoghossian et al., 1994). However, several other reports have indicated the 
importance of cerebral hemodynamics in association with the risk of ischemic stroke in 
patients with CS or occlusion (Silvestrini et al., 1996; Yamauchi et al., 1996; Markus and 
Cullinane, 2001; Vernieri et al., 2001). 
 
 
MANAGEMENT 
 
In patients with SCS, the benefit of CEA on final outcome has been established in large 
randomized trials (North American Symptomatic Carotid Endarterectomy Trial, 1991; 
European Carotid Surgery Trialists’, 1998). Because of reduced risk for artery-to-artery 
embolism, CEA may also ameliorate the hemodynamic state, as suggested by 
postoperative improvement in cerebrovascular reactivity and CBF (Vanninen et al., 1995; 
Kluytmans et al., 1998a; Wiart et al., 2000; Markus and Cullinane, 2001; Rutgers et al., 
2001). Several studies including both ACS and SCS patients have detected hemodynamic 
melioration after CEA (Hartl et al., 1994; Kluytmans et al, 1998a; Wiart et al, 2000; 
Rutgers et al, 2001), but some findings suggest differences in hemodynamics between 
these patient populations (Silvestrini et al, 1996; Derdeyn et al., 1999). CEA is beneficial 
in patients with a surgically accessible SCS of over 70%, who are otherwise healthy, and 
have had hemispheric TIAs or minor hemispheric infarcts (Barnett et al., 2002). In 
carefully selected patients, an early CEA (<four weeks after stroke) was found to be 
beneficial in preventing carotid occlusions and recurrent strokes and reducing costs of 
medical care (Kahn et al., 1999).  
In ACS patients, the advantage of CEA is less clear (Chambers et al, 2002). In this 
subgroup, because CEA appears to offer only a marginal benefit, surgeons must have an 
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exceptionally low complication rate. Therefore, the current preferred treatment for this 
patient group is medical. However, a subgroup of ASC patients may benefit more 
strongly from CEA, but the characteristics of such a group have not yet been determined 
(Barnett et al, 2002). In patients with total or subtotal carotid occlusion, the choice of 
treatment is even more challenging (Klijn et al, 1997). 
Despite information about the utility of CEA in different subgroups, the 
counseling of individual patients is difficult because of the wide spectrum of individual 
comorbidities and possible outcomes (Bogousslavsky et al, 2000; Bamford, 2001). The 
future management of CS may change based on results of ongoing and forthcoming 
studies with functional imaging techniques (PI, positron emission tomography (PET), 
single photon emission computed tomography (SPECT), and CT perfusion imaging) 
since all previous multicenter studies have been founded on the anatomy of the carotid 
artery imaged with traditional angiography, and not the functional state of the brain. 
 
 
LEUKOARAIOSIS (LA) 
 
EPIDEMIOLOGY 
 
The term LA or Binswangers disease (Babikian and Ropper, 1987) refers to radiological 
findings of bilateral and either patchy or diffuse areas of hypodensity of the WM on CT 
or hyperintensity on T2-weighted MRI (Hachinski et al, 1987). LA is a common finding, 
and its frequency in older patient groups has ranged between 21% and 100% depending 
on the imaging method used and the study population (Pantoni and Garcia, 1995); its 
exact frequency is still under debate since no agreement between the various LA rating 
scales exists between centers (Mäntylä et al., 1997; Scheltens et al., 1998; Pantoni et al., 
2002), and CT and different sequences of MRI detect LA differently (Mäntylä et al., 
1999a). Thus, classification of leukoaraiotic lesions remains problematic. 
Risk factors for LA in part overlap those for ischemic stroke (Pantoni and Garcia, 
1995). Risk increases with age, especially beyond the age of 65 years, even in 
neurologically and neuropsychologically healthy subjects (Pantoni and Garcia, 1995; Mrak 
et al, 1997; Shintani et al., 1998; van Gijn, 1998; Hamill and Pilgrim, 2000; Longstreth et 
al., 2001). Failure of blood supply in the small arteries of the brain (Oishi and Mochizuki, 
1998), chronic brain ischemia due to various reasons, diabetes (Pantoni and Garcia, 1995; 
Mäntylä et al., 1999b), brain blood pressure dysregulation, and especially high systemic 
pressure (Matsubayashi et al., 1997; Shintani et al, 1998; Wiszniewska et al., 2000) are 
associated with LA. Disturbed flow of CSF (Pantoni and Garcia, 1997) increases 
periventricular WM changes, and LA is found in AD, in vascular dementia (Barber et al., 
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1999), and in several hereditary diseases including CADASIL (cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalography) (Pantoni and 
Garcia, 1995).  
 
 
PATHOPHYSIOLOGICAL AND CLINICAL ASPECTS  
 
Chronic cerebral ischemia and hypoperfusion due to various reasons are thought to be 
the main etiologies for LA. However, the pathogenesis and clinical significance of LA are 
incompletely understood, and because the term LA overall is controversial in the 
literature, no universal conclusions can be drawn (Pantoni and Garcia, 1997). Some 
individuals, regardless of the severity of LA, remain neurologically and 
neuropsychologically asymptomatic for prolonged periods (Rao et al., 1989), while others 
develop cognitive impairment (Ylikoski et al., 1993; Breteler et al., 1994; Yamauchi et al., 
2000), mood and psychiatric disorders, gait disturbance, urinary dysfunctions (Sakakibara 
et al., 1999), disability, and even dementia (Babikian and Ropper, 1987; Tarvonen-
Schröder et al., 1996; Barber et al, 1999). In general, LA does seem to increase morbidity 
and mortality (Briley et al., 2000), and to enhance the risk for ischemic stroke (Pantoni 
and Garcia, 1995; Steifler et al., 2002; Inzitari, 2003). 
In autopsy studies, leukoaraiotic regions have been found to consist of 
periventricular venous collagenosis (Moody et al., 1995; Brown et al., 2002), perivascular 
degeneration, arteriolar tortuosity (Brown et al, 2002), lacunar infarcts, incomplete 
infarctions, apoptosis (Brown et al., 2000; Brown et al, 2002), gliosis, axonal loss, and 
proliferation of glial cells (Pantoni and Garcia, 1997; Murdoch, 2000). Axonal loss leads 
to an increase in water content of affected brain tissue. The findings suggest that an 
inflammatory reaction, changes in myelin, and compromised axonal transport, all of 
which are affected in chronic ischemia, may play important roles in the pathophysiology 
of LA (Akiguchi et al., 1997; Kurumatani et al., 1998; Brown et al, 2002). Further support 
for the role of chronic ischemia comes from the markers of chronic endothelial 
dysfunction and prothrombic changes in LA patients (Hassan et al., 2003). 
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MANAGEMENT 
 
Although the prognosis of an individual LA patient is unpredictable, the prognosis of 
leukoaraiotic patients in general, especially in the most severe groups, is worse than for 
those without this condition (Briley et al, 2000). Therefore, the need for primary and 
secondary preventive measures is clear (Inzitari et al, 1997). As the etiology and 
pathogenesis of LA seem to be manifold, a single best course of treatment does not exist, 
but some basic guidelines can be followed. Since chronic brain ischemia is the most 
important etiology, preventive and management methods should be targeted against it 
(Pantoni and Garcia, 1995; Inzitari et al, 1997). Antithrombotic agents, such as aspirin 
with or without dipyridamole and clopidogrel, may represent an important component in 
prevention, especially in subjects with risk factors for vascular diseases. Equally important 
is aggressive treatment of risk factors for vascular diseases, hypertension, diabetes, 
dyslipidemia, and heart diseases, at the latest after the finding of severe LA lesions, and all 
subjects should be motivated to give up smoking and excessive consumption of alcohol. 
Therapies that help to stabilize the endothelium, such as statins and angiotensin 
converting enzyme inhibitors, may also have a role in treating patients with LA (Hassan 
et al, 2003). 
 
 
 
IMAGING METHODS 
 
 
PRINCIPLES OF MAGNETIC RESONANCE IMAGING (MRI) 
 
MRI is based on measuring relaxation behavior of hydrogen atoms when these are placed 
in an external magnetic field and transiently perturbed with radiowaves at a suitable 
frequency. Hydrogen atoms with positively charged spinning nuclei are surrounded by 
dipolar magnetic fields. When placed into an external magnetic field, the nuclei align 
themselves with the magnetic field. Slightly over half of the nuclei align parallell and the 
rest antiparallell to the magnetic field. The net effect is a weak magnetic vector aligned in 
the direction of the external magnetic field – a phenomenon known as longitudinal 
magnetization. 
The nuclei precess along the external magnetic field lines at a certain precession 
frequency. This frequency is dependent on the external magnetic field, which is usually 
0.1-3 Tesla (T) in the MRI equipment used in human studies. The stronger the magnetic 
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field of the MRI equipment, the higher the precession frequency of the nuclei. This 
frequency can be calculated by using the Larmor equation as follows: 
 
ω0=γB0 
 
in which ω0 is the precession frequency, B0 is the strength of the external magnetic field, 
and γ is the gyro-magnetic ratio. 
In MRI, a radiofrequency (RF) pulse at the same frequency as the precession 
frequency (calculated by the Larmor equation) is applied through the transmitter coil, and 
the nuclei that were aligned with the external magnetic field absorb the energy and 
reverse their direction. The longitudinal magnetization decreases, and as the nuclei begin 
to precess synchronically, a transversal magnetization is established. This produces a 
voltage (the magnetic resonance signal) in the receiver coil. The RF pulse is then switched 
off, allowing the nuclei to relax back to their original alignment.  
The relaxation time, in which 63% of the magnitude of the original longitudinal 
vector is returned to its original alignment, is called T1 (spin-lattice) relaxation time 
(=longitudinal relaxation). Spin-lattice refers to the excited proton (spin) energy transfer 
to its surroundings (lattice) rather than to another spin. When the RF emission is 
switched off, the synchronic precession begins to disappear. The relaxation time at which 
37% of the synchronic precession disappears is called T2 (spin-spin) relaxation time 
(=transversal relaxation). Spin-spin refers to the energy transfer from one excited proton 
to another. In biological tissues, T1 is about 300 to 2000 ms, and T2 about 30 to 150 ms; 
water having a substantially longer T1 and T2 than lipid-containing tissues. 
In MRI, the object measured is a proton and its relaxation behavior. The proton 
measured in conventional MRI is the proton of a hydrogen atom since it is present 
abundantly in all tissues. Therefore, MR images are basically gathered from water and 
lipids in various tissues. An MR image represents a display of spatially localized signal 
intensities. These signal intensities are represented on the final image as points of relative 
brightness (hyperintensity) or darkness (hypointensity), depending on the strength of the 
magnetic field, imaging technique (pulse sequence), tissue characteristics (T1 and T2 
relaxation times, the density of mobile protons), and other factors, such as magnetic 
susceptibility, chemical shift, diffusion, and blood flow. Images are T1-weighted, T2-
weighted, or proton density-weighted depending on the pulse sequence characteristics, 
repetition time (TR), and echo time (TE) chosen. T1-weighting is produced by the choice 
of a short TE to minimize the effect of T2, along with a short TR. T2-weighting is 
accomplished when a long TR is combined with a long TE. A long TR with a short TE 
eliminates both T1 and T2 effects, and results in a proton density-weighted image. 
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Dephasing, produced by molecular interactions and spatial variation of the external 
magnetic field, shortens the measured T2, and is termed T2* (T2 star). 
In MRI studies, many sequences are either spin-echo (SE) or gradient-echo (GE) 
based. In a SE sequence, a 90° RF pulse is followed by one or more 180° RF pulses to 
rephase the dephasing protons, thus resulting in one or more SEes. With this sequence, 
T1-weighted, T2-weighted, or proton density-weighted images can be achieved. In a GE 
sequence, a flip angle smaller than 90° is added, and instead of a 180° RF pulse, a 
gradient field, is added to the existing magnetic field. Whereas SE are more sensitive to 
microvasculature than GE, GE-based sequences exhibit better signal-to-noise ratios. 
Being a paramagnetic substance, gadolinium diethylenetriaminepenta-acetic acid 
(Gd-DTPA) is used as a MR contrast medium. The contrast medium changes the signal 
intensity by shortening T1 and T2 in their surroundings. This results in a signal increase 
in T1-weighted images and a signal decrease in T2-weighted images. T1-weighted images 
are therefore preferred after contrast medium injection in conventional MRI (Stark and 
Bradley, 1992; Horowitz, 1995; Haacke et al., 1999). 
MRI is contraindicated in subjects with ferromagnetic implants, material, or 
devices because of risks associated with possible movement or dislodgement of the 
object and potential hazards, including induction of an electric current, excessive heating, 
and misinterpretation of an artifact produced by the presence of the object as an 
abnormality. Factors that can influence the risk are strength of the static and gradient 
magnetic fields, degree of ferromagnetism of the object, mass and geometry of the object, 
location and orientation of the object in situ, and length of time that the object has been 
in its place. All of these factors should be carefully considered before a subject with a 
ferromagnetic object undergoes MRI (Shellock et al., 1993). 
 
 
DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (DWI) 
 
METHODOLOGY 
 
DWI provides an image contrast that is dependent on the molecular motion of water 
(diffusion), which is called Brownian movement. After Stejskal and Tanner (1965) 
described a DW SE T2-weighted pulse sequence with two extra gradient pulses equal in 
magnitude and opposite in direction, it took several decades for that sequence to become 
clinically feasible (Le Bihan et al, 1986) due to limitations of MR equipment. 
In DWI, the water molecules in the magnetic field are labelled with rapidly 
changing magnetic gradients. Short but strong diffusion gradients are applied 
symmetrically before and after a 180° RF pulse in conventional SE T2-weighted 
sequence. According to Fick’s law, true diffusion is the net movement of molecules due 
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to a concentration gradient. With MRI, however, molecular motion due to concentration 
gradients cannot be differentiated from molecular motion due to pressure gradients, 
thermal gradients, ionic interactions, or perfusion. Therefore, when measuring the 
molecular motion (diffusion) with DWI, only the ADC can be calculated. The ADC 
maps can demonstrate diffusion differences (or differences in signal intensities) in tissues 
without interference of these other matters. The signal intensity (SI) of a DW image is 
best expressed as 
 
SI=SI0 x exp (-b x ADC) 
 
where SI0 is the signal intensity on a T2-weighted (b=0) image, and 
 
b=γ2 G2 δ2 (∆ – δ/3) 
 
where b is the diffusion sensitivity factor, γ is the gyromagnetic ratio, G is the magnitude 
of gradient pulses, δ is the gradient duration, and ∆ is the time between two balanced 
gradient pulses. 
With the development of high-performance gradients, DWI has become clinically 
feasible. It can be performed with a SE echo-planar imaging (EPI) sequence, a sequence 
that markedly decreases imaging time and motion artifacts, and increases sensitivity to 
signal changes due to molecular motion. Most clinically used MR equipment are capable 
of EPI. However, EPI may be associated with distortions (Haselgrove and Moore, 1996), 
N/2 ghost images, susceptibility/chemical shift artifacts, and eddy current artifacts 
(Edelman et al., 1994; Jezzard et al., 1998), especially if the systems are unstable or 
unoptimized. Other methods performing DWI with and without echo-planar gradients 
have also been developed (Brockstedt et al., 1998; Bammer et al., 1999). 
Diffusion is not isotropic (same in all directions) in biological tissues since water 
diffuses more easily along the direction of myelinated tracts rather than across them 
(diffusion anisotropy) (Harada et al., 1991; Sakuma et al., 1991). Because cellular 
structures are distributed anisotropically, the measurement of diffusion is also direction-
dependent (Sakuma et al, 1991), emphasizing the need for measuring diffusion in several 
directions. Thus, to obtain a rotationally invariant estimate of isotropic diffusion, DW 
images must be acquired in at least three orthogonal directions (Ulug et al., 1997). The 
postprocessing of these images begins with the calculation of the natural logarithms of 
the images, which should be averaged to form a rotationally invariant resultant image. 
Using a linear least-squares regression on a pixel-by-pixel basis, the resultant image and 
the natural logarithm of the reference T2-weighted image are fitted to the b values (see 
below). The negative slope of the fitted line is the average ADC (ADCav). 
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Diffusion-weighting is expressed by a b value, which is dependent on the 
sequence characteristics. The b value increases with increasing diffusion-weighting. 
Sufficient diffusion-weighting is usually achieved with b values of 800-2000 s/mm2, 1000 
being the most common clinically used b value. However, in some studies, the optimal b 
value for contrast in, for example, acute ischemic lesions has been found to be 1662, so a 
b value of 1500 may be better than the standard b value of 1000 (Pereira et al., 2002). 
Quantitative measurements of ADC (and ADCav) depend on b values (Yoshiura et al., 
2001; Wilson et al., 2002). ADCav estimates with two b values (usually b=0 and b=1000) 
have been found to be adequate for measuring diffusion in the human brain, as they 
provide good agreement with ADCav estimates with six b values (Xing et al., 1997; 
Burdette et al., 1998) and shorten the imaging time substantially. 
 
 
IMAGING OF THE HEALTHY BRAIN 
 
The ADCav values in the healthy human brain have been found to range between 0.8 and 
1.4 x10-3 mm2/s in the cortical GM, 0.6 and 0.9 x10-3 mm2/s in the WM, 0.7 and 1.1 x10-
3 mm2/s in the basal ganglia and thalamus, and 2.2 and 3.3 x10-3 mm2/s in the CSF 
(Chien et al., 1990; Le Bihan et al., 1992; Gideon et al., 1994; Falconer and Narayana, 
1997; Engelter et al., 2000b; Tanner et al., 2000) (Table 1). With age, these values appear 
to remain fairly constant in the cortical GM and to increase in the CSF, whereas in the 
WM, basal ganglia, and thalamus, the findings have varied considerably, and no firm 
conclusions can be drawn (Gideon et al, 1994; Engelter et al, 2000b; Chen et al., 2001; 
Nusbaum et al., 2001; Rovaris et al., 2003). In neonates with incomplete myelination of 
the brain, ADCav values are clearly higher than in adults, especially in the WM (Toft et al., 
1996; Neil et al., 1998; Tanner et al, 2000; Zhai et al., 2003). During maturation of the 
brain ADCav values decrease to the level of those in the adult brain. No studies have 
reported differences between the genders based on ADCav values. 
Quantitative measurements of ADCav values for normal and pathologic structures 
are important when either focal or diffuse abnormalities are suspected because minor 
changes may be difficult to detect visually. However, the normal and absolute ADCav 
values may differ between centers, as several factors affect these values. The variability in 
measurement protocols, imaging characteristics, and sequence characteristics (b value, 
diffusion time, gradient strength, TE, TR, cardiac gating) may influence ADCav values 
considerably (Yoshiura et al, 2001; Wilson et al, 2002) and must be considered when 
comparing values between centers and studies. 
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Reference N Age    
  M/F Years GM WH BG/THA CSF 
       
Chien et al., 1990  13 / 5  20-35 1.0±0.2 0.7±0.1 na 2.2±0.2 
       
Engelter et al., 2000  16 /16  24-80 na 0.7±0.0 0.7±0.0 na 
       
Falconer et al., 1997   6 / 0  na 0.9±0.1 0.9±0.0 1.0±0.2 na 
       
Gideon et al., 1994  11 / 6  22-76 1.4±0.2 0.6±0.2 1.1±0.3 3.1±0.2 
       
Le Bihan et al., 1992  review  na 0.8±0.0 0.9±0.1 na 2.9±0.1 
       
Tanner et al., 2000   5 / 0  20-30 0.9±0.2 0.8±0.1 na 3.3±0.5 
 
Table 1. ADCav values (x10-3 mm2/s) ± SDs of the healthy human brain. GM=gray 
matter, WM=white matter, BG=basal ganglia, THA=thalamus, BG/THA=BG and/or 
THA, CSF=cerebrospinal fluid, M=males, F=females, na=data not available. 
 
 
 
IMAGING OF ISCHEMIC STROKE 
 
DWI reveals acute ischemic regions in the brain as bright areas within 2-3 minutes of 
focal ischemia induction in experimental stroke models (Moseley et al., 1990; Röther et 
al., 1996; Li et al., 1999; Hoehn et al., 2001), and as soon as an acute stroke patient is 
available for imaging studies (Baird and Warach, 1998; Gonzalez et al, 1999). In 
hyperacute stage (<6 hours), it is superior to CT and conventional MRI for diagnosing 
stroke (Warach et al., 1992; Lutsep et al., 1997; van Everdingen et al., 1998; Gonzalez et 
al, 1999; Fiebach et al., 2002; Mullins et al., 2002; Saur et al., 2003), and is especially 
useful in differentiating acute ischemic lesions from chronic ones (Marks et al., 1996; 
Singer et al., 1998; Lindgren et al., 2000; Oliveira-Filho et al., 2000). It even detects small 
(4 mm) and neurologically silent lesions, which often remain undiagnosed by CT or 
conventional MRI (Warach et al., 1995; Britt et al., 2000; Fiebach et al, 2002). 
A rapid decrease in ADCav values occurs in acute brain ischemia (Warach et al, 
1992; Burdette et al., 1999; Weber et al., 2000; Hoehn et al, 2001; Ahlhelm et al., 2002). 
Thus, hyperacute and acute ischemic lesions of the brain appear hypointense on the 
ADCav maps. The ADCav values of the ischemic lesion begin to increase over 5 to 10 
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Reference N  Time after Stroke Onset  
    <6 H 6-48 H 2-14 D 15-60 D >60 D 
       
Ahlhelm et al., 2002 52 0.3±0.6 0.2±0.7 0.3±0.2 na 2.0±na 
       
Latour et al., 2002 31 0.6±0.1 na na na na 
       
Lutsep et al., 1997 26 0.3±0.3 0.6±0.1 0.5±0.2 1.6±0.9 2.6±0.4 
       
Marks et al., 1996 29 na 0.4±0.1 0.4±0.1 1.6±0.8 na 
       
Schlaug et al., 1997 101 0.5±0.2 0.5±0.1 0.6±0.1 1.5±0.2 na 
       
van Everdingen et al., 42 na na 0.7±0.1 na na 
1998       
Warach et al., 1995 40 0.5±0.2 0.4±0.2 0.5±0.2 1.9±0.6 na 
 
Table 2. ADCav values (x10-3 mm2/s) ± SDs of ischemic strokes of various ages. 
N=number of included patients, na=data not available, H=hours, D=days. 
 
 
 
 
days, approaching normal brain ADCav values, a phenomenon called 
pseudonormalization (Warach et al, 1995; Burdette et al, 1999; Ahlhelm et al, 2002). At 
this stage, the ischemic lesion disappears on DW images. In chronic brain infarcts, the 
ADCav values are substantially higher than those of normal brain tissue (Warach et al, 
1992; Weber et al, 2000; Ahlhelm et al, 2002), as diffusion in necrotic regions approaches 
that of free water due to cavitation and replacement of brain tissue with water. The 
typical increase of ADCav values over time after acute ischemic stroke occurs, however, 
slower in small lacunar lesions (Geijer et al., 2001). 
The ADCav values of ischemic stroke in hyperacute phase (<6 hours) have been 
found to range between 0.29 and 0.64 x10-3 mm2/s, in acute phase (<48 hours) between 
0.15 and 0.63 x10-3 mm2/s, in subacute phase (<2 weeks) between 0.34 and 0.73 x10-3 
mm2/s, in recent chronic phase (<2 months) between 1.5 and 1.9 x10-3 mm2/s, and in 
later chronic phase (>2 months) >2.0 x10-3 mm2/s (Warach et al, 1995; Marks et al, 1996; 
Lutsep et al, 1997; Schlaug et al., 1997; van Everdingen et al, 1998; Ahlhelm et al, 2002; 
Latour and Warach, 2002) (Table 2). 
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DWI has become an essential part of the clinical imaging of patients with 
hyperacute stroke, as it is a reliable tool in weighing the possibilities for active 
intervention with thrombolytic therapy. The lesion seen on the hyperacute DW images 
generally predicts the lesion core, the region of irreversible damage. However, reversal of 
the DW image lesion back to normal without intervention has also been seen (Grant et 
al., 2001; Fiehler et al., 2002a; Fiehler et al., 2002b), although this does not confirm that 
the ischemic lesion tissue has fully recovered (Li et al, 1999). DWI lesion volumes have 
been said correlate with the final outcome of acute stroke (van Everdingen et al, 1998; 
Wardlaw et al., 2002). However, this depends on the time point of the DWI study: 
obviously, the correlation is better at later time points than in the hyperacute stages 
(Schellinger et al., 2001). The combination of DWI with clinical data and PI (see below) 
clearly increases the reliability of the prediction. 
Limitations of the DWI in stroke imaging include possible overestimation of 
ADCav values due to risk of contamination of ischemic lesions with the CSF (Latour and 
Warach, 2002). This can be counteracted with the use of a CSF suppression technique 
(Latour and Warach, 2002) or with special care taken in selecting the regions of interest 
(ROI) near CSF spaces. In addition to the contamination risk, the ischemic lesions are 
heterogeneous, containing layers of decreased, pseudonormal, and increased pixels of 
ADCav values. 
 
 
IMAGING OF CAROTID STENOSIS AND ENDARTERECTOMY 
 
DWI has a role in the imaging of CS and carotid occlusion patients, although its 
applicability to changes induced by these circumstances has been tested only recently and 
in a fairly small number of studies (Szabo et al., 2001; Kang et al., 2002; Kastrup et al., 
2002). In these studies, the primary interest was on stroke patterns and visually detected 
ischemic lesions of such patients. Its role in investigating changes in diffusion parameters 
over time and its possibilities in differentiating ACS patients from SCS patients have not 
been studied. The stroke patterns of CS and occlusion patients are heterogeneous, but 
certain patterns seem to be more common (Szabo et al, 2001; Kang et al, 2002; Kastrup 
et al, 2002). Especially multiple embolic lesions and additional hemodynamic alterations 
within border zone regions appear to be overrepresented in these patient groups (Szabo 
et al, 2001; Kang et al, 2002; Kastrup et al, 2002). 
The detection of minor and silent infarctions after CEA or carotid stent 
implantation is possible with DWI (Müller et al, 2000; Feiwell et al, 2001; Jaeger et al, 
2002), but its ability to detect other changes induced by CEA has not been previously 
tested. CEA is known to be associated with the risk of cerebral embolization and 
hypoperfusion, and thus, is accompanied by a substantial number of small areas of brain 
 30 
tissue-at-risk for irreversible ischemia (Müller et al, 2000). However, the incidence of 
silent ischemic lesions of embolic origin in DW images is low, confirming CEA to be a 
safe procedure for CS patients, when appropriately performed (Barth et al., 2000; Feiwell 
et al, 2001). 
 
 
 
IMAGING OF LEUKOARAIOSIS 
 
DWI provides information on the extent and formation of LA and elucidates the 
mechanism of LA in vivo (Okada et al, 1999). On DW images, leukoaraiotic regions are 
hypointense and are therefore hyperintense on ADCav maps (Okada et al, 1999; 
Mascalchi et al., 2002a). Fractional anisotropy is decreased and ADCav values increased in 
these regions (Jones et al., 1999). Additionally, the whole brain ADC histogram seems to 
correlate with the severity of LA (Mascalchi et al., 2002b). As discussed earlier, LA is 
characterized by axonal loss and proliferation of glial cells (Pantoni and Garcia, 1997). 
Especially axonal loss, leading to an increase in water content of the tissue, may 
contribute to the ADCav increase since axons produce significant hindrance to water 
diffusion. The ADCav values of leukoaraiotic regions have been found to be around 1.2 
x10-3 mm2/s (Jones et al, 1999; O'Sullivan et al., 2001), but these values have not been 
extensively studied. 
Besides the visually detected leukoaraiotic regions, DWI reveals changes in 
normal-appearing WM of subjects with LA (Jones et al, 1999; O'Sullivan et al, 2001; 
Mascalchi et al, 2002a). A change in the normal-appearing WM may be due to primary 
phases of relative hypoperfusion and chronic ischemia, even though these cannot be 
visually detected on conventional MR images. ADCav values of normal-appearing WM in 
patients with LA or another WM disease, multiple sclerosis (MS), range between 0.74 and 
0.84 x10-3 mm2/s, and may even reach 1.1 x10-3 mm2/s, although in the case of very high 
ADCav values, one may suspect contamination of the ROIs with the leukoaraiotic lesions 
(Droogan et al., 1999; Jones et al, 1999; Cercignani et al., 2001; O'Sullivan et al, 2001; 
Caramia et al., 2002; Guo et al., 2002). ADCav values of normal-appearing WM of LA and 
MS patients were found to be substantially higher than those of healthy subjects (Table 
3). 
ADCav values of acute ischemic lesions of the brain are lower than those of 
normal-appearing WM or leukoaraiotic regions. As ADCav values of chronic brain 
infarcts are clearly higher than those of normal brain tissue and regions of LA, it seems 
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Reference   N Age (Years)   
   P / C   P / C Disease Patients Controls 
      
Caramia et al., 2002  19 /12  30 /30 MS 0.77±0.02 0.75±0.02 
      
Cercignani et al., 2001  30 /18  38 /38 MS 0.84±0.04 0.82±0.04 
      
Droogan et al., 1999  35 /12  44 /34 MS 0.78±na 0.76±na 
      
Guo et al., 2002  26 /26  40 /40 MS 0.74±0.04 0.73±0.04 
      
Jones et al., 1999   9 /10  62 /66 LA  1.1±0.3 0.75±0.1 
      
O'Sullivan et al., 2001  30 /17  70 /72 LA 0.79±0.04 0.75±0.04 
 
Table 3. ADCav values (x10-3 mm2/s) ± SDs of normal-appearing WM in subjects with 
LA or multiple sclerosis. LA=leukoaraiosis, MS=multiple sclerosis, P=patients, 
C=controls, na=data not available. 
 
 
 
that DWI may be useful in distinguishing ischemic stroke lesions of acute and chronic 
stage from regions of LA. Comparative studies are, however, rare in the literature (Calli et 
al., 2003). 
 
 
IMAGING OF OTHER DISEASES 
 
Utility of DWI has been investigated in several diseases besides ischemic disorders. It has 
been found to be an especially useful method for the study of MS, a devastating 
progressive neurological disease of young adulthood (Droogan et al, 1999; Cercignani et 
al., 2000; Nusbaum et al., 2000; Schaefer et al, 2000; Cercignani et al, 2001; Guo et al., 
2001; Caramia et al, 2002; Guo et al, 2002; Rovaris et al., 2002). Various dementias 
(Hanuy et al., 1998; Hanuy et al., 1999; Yoo et al., 2002), epilepsy (Helpern and Huang, 
1995; Hugg et al., 1999), Parkinson’s disease (Adachi et al., 1999), cerebral infections 
(Demaerel et al., 1999; Na et al., 1999; Schaefer et al, 2000), cystic abscesses, trauma 
(Schaefer et al, 2000; Arfanakis et al., 2002), tumors (Le Bihan et al, 1992; Kono et al., 
2001), venous thrombosis (Chu et al., 2001), Creutzfeldt-Jakob disease (Demaerel et al., 
2003), and hemorrhages (Schaefer et al, 2000) have also increasingly been studied with 
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DWI, and the results have been promising. DWI is an appropriate tool for 
neuropathological investigations in vivo, as it detects changes which have previously only 
been diagnosed at autopsy. 
 
 
DIFFUSION TENSOR IMAGING 
 
As briefly discussed earlier, diffusion is a three-dimensional process, and molecular 
mobility is not the same in all directions in biological tissues. This phenomenon is called 
diffusion anisotropy. In the GM, diffusion is relatively isotropic, whereas diffusion in the 
WM is highly anisotropic due to the specific organization of the WM in bundles of more 
or less myelinated axonal fibers running in parallel. Since only the molecular displacement 
that occurs along the direction of gradient pulses is visible, the effect of diffusion 
anisotropy can easily be detected by observing variations in diffusion measurements after 
the direction of gradient pulses is changed. With diffusion tensor imaging, anisotropy 
effects can be extracted, characterized, and exploited, which provides more detailed 
information on tissue microstructure in healthy and diseased brains (Shimony et al., 1999; 
Sorensen et al., 1999b; Le Bihan et al., 2001). WM tracts can be followed from the 
cerebral cortex to the spinal cord, and the diseases involving these tracts can be studied 
(Pierpaoli et al., 1996; Conturo et al., 1999; Eriksson et al., 2002; Mamata et al., 2002). 
Diffusion tensor imaging makes the imaging of the diffusional changes in the brain even 
more accurate. 
 
 
PERFUSION MAGNETIC RESONANCE IMAGING (PI) 
 
METHODOLOGY 
 
Brain perfusion refers to the microcirculation of the brain. Microcirculation comprises 
the blood circulation in capillary networks and the exchange of oxygen and nutrients 
between the blood and the brain tissue. The effectiveness of brain perfusion depends on 
blood pressure, blood velocity, characteristics of the capillary network, capillary wall 
permeability, and diffusion rates of oxygen and nutrients. In the healthy brain, perfusion 
is symmetrical, and higher in the GM than in the WM. Brain perfusion is usually 
quantified in terms of mL/100 g (CBV) (Belliveau et al, 1990; Rosen et al, 1991), mL/100 
g/min (CBF) (Østergaard et al, 1996a; Østergaard et al, 1996b), or seconds (MTT, the 
CBV:CBF ratio) (Meier and Zierler, 1954; Stewart, 1984). 
PI can be performed using susceptibility-based techniques (DSC MRI and blood 
oxygenation-level dependent imaging, BOLD) or arterial spin-labeling (Siewert et al., 
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1997; Calamante et al., 1999; Vonken et al., 1999; Li et al., 2000; Barbier et al., 2001; 
Hoehn et al, 2001; Wang et al., 2002). DSC MRI with either SE- or GE-based sequences 
is mostly used clinically (Boxerman et al., 1995; Simonsen et al., 2000; Speck et al., 2000; 
Yamada et al., 2002), whereas BOLD imaging is largely utilized for cortical activation 
studies. 
DSC MRI has shown promise in assessing cerebral perfusion since it is widely 
available, offers a good spatial and temporal resolution, does not expose subjects to 
ionizing radiation, is minimally invasive, and covers a large spatial volume. It is 
performed by combining the simultaneous use of Gd-DTPA, preferably in higher doses 
(>0.15 mmol/kg) than those used clinically (Griffiths et al., 2001), and a rapid collection 
of the MR signal during the passage of the Gd-DTPA bolus through the brain (Villringer 
et al, 1988). Gd-DTPA produces a strong susceptibility effect, extending approximately 5 
µm from the capillaries to the brain tissue, and causes dephasing of the spins. The 
susceptibility difference between Gd-DTPA and the brain tissue sets up local magnetic 
field gradients, creating a loss of phase coherence and a decrease in signal intensity in the 
tissue surrounding the capillaries. This results in darkening of the images. In healthy 
brains, the signal intensity declines as Gd-DTPA reaches the brain, whereas in brain 
ischemia, the ischemic lesion remains bright, and a sharp contrast between normally 
perfused and hypoperfused regions can be seen. After a few seconds, Gd-DTPA is 
flushed away from the brain tissue, and the entire brain appears bright on subsequent 
images (Le Bihan, 1990; Hossmann and Hoehn-Berlage, 1995; Barbier et al, 2001; Cha et 
al, 2002). 
The raw images obtained with DSC MRI have to be postprocessed for the 
determination of the absolute hemodynamic parameters, CBV, CBF, and MTT. 
Extensive postprocessing is needed for the more accurate measurement of perfusion 
changes in quantitative terms (Calamante et al, 1999); several methods to accomplish this 
have been tested (Perkiö et al., 2002). One of the most common of these is the 
deconvolution approach, described in detail in the Subjects and Methods section. The 
term deconvolution refers to the determination of CBF and MTT from arterial and tissue 
concentration time curves (Østergaard et al, 1996a). Different posprocessing methods 
give slightly different perfusion values (Smith et al., 2000; Wirestam et al., 2000), which 
have to be considered when comparing the results between centers and studies 
(Calamante et al, 1999; Vonken et al, 1999; Vonken et al., 2000). 
DSC MRI data analysis for producing quantitative results has inherent limitations 
and thus far has not fulfilled the criteria of strict quantification (Weisskoff et al., 1993; 
Calamante et al., 2000; Kiselev, 2001; Sorensen, 2001; Calamante et al., 2002). For one 
thing, the quantitative analysis of perfusion data is based entirely on determining an 
arterial input function (AIF), which cannot accurately be determined by DSC MRI 
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(Perthen et al., 2002). Whereas the shape of the function can be determined with rather 
good accuracy, the height of the function remains arbitrary (Østergaard et al, 1996b). The 
proportionality factor relating MR signal change to concentration of Gd-DTPA is not 
equal in brain tissue and larger vessels. Therefore, the size of the AIF has to be 
normalized to the injected dose of Gd-DTPA to produce quantitative results. Further, 
the microvascular hematocrit is approximated to be two-thirds of the systemic blood 
hematocrit (Østergaard et al, 1996b). However, as a complex function of vessel size and 
physiological conditions is needed to calculate it, it may be subject-dependent. Since the 
hematocrit ratio is directly associated with the scale factor relating tissue first-pass area to 
the CBV, any errors in the hematocrit ratio are directly seen in the quantitative value of 
the CBV. In addition, the orientation of the MCA with respect to the main magnetic field 
has a major effect on the signal. Finally, a normalization factor for producing absolute 
CBF by DSC MRI has been introduced which compares MR CBF with PET CBF among 
normal subjects (Østergaard et al., 1998a; Østergaard et al., 1998b). However, the 
assumption that the same fraction of cardiac output reaches the brain of all subjects may 
not hold true with aging. 
 
 
IMAGING OF THE HEALTHY BRAIN 
 
Brain perfusion of the normal human brain has been investigated for decades with 
different imaging techniques and variable results. Quantitative values have traditionally 
been studied with PET, a golden standard for absolute perfusion parameters, whereas 
relative values of the brain perfusion have been measured with DSC MRI and SPECT. 
One of the goals in DSC MRI methodology has, however, been the technical 
development for obtaining these absolute values. These values for healthy brain perfusion 
according to the literature concerning DSC MRI, PET, and 133Xe inhalation methods are 
as outlined in the next three paragraphs (Tables 4a-c). As seen in these paragraphs, the 
results are highly variable, and no method can be considered better than the others in 
determining these parameters. 
The CBV in units of mL/100 g in the GM has been found to range between 4.1 
and 6.5, and in the WM between 2.5 and 3.6, the ratio of GM to WM being 1.4-2.4 
(Yamaguchi et al., 1986; Leenders et al., 1990; Nighoghossian et al., 1997; Petrella et al., 
1998; Schreiber et al., 1998; Koshimoto et al., 1999; Vonken et al, 1999; Hunsche et al., 
2002) (Table 4a). 
The CBF in units of mL/100 g/min in the GM ranges between 37.3 and 89.1, 
and in the WM between 16.0 and 35.8, with the ratio of GM to WM being 1.7-5.2 
(McHenry et al., 1978; Naritomi et al., 1979; Pantano et al., 1984; Yamaguchi et al, 1986;
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Reference   N Age Modality    
   M/N Years   GM WM GM:WM 
       
Hunsche et al., 2002   7 / 3 57±13 DSC MRI na na 2.0±0.3 
       
Koshimoto et al., 1999   8 /11 25-73 DSC MRI 4.1±0.8 2.9±0.4 1.4±na 
       
Leenders et al., 1990  18 /16 22-82 PET 4.6±1.0 2.6±0.4 1.8±na 
       
Nighoghossian et al.,   8 / 2 31-79 DSC MRI na na 2.4±na 
1997       
Petrella et al., 1998  30 / 0 23-82 DSC MRI na na 1.9±na 
       
Schreiber et al., 1998  13 / 0 24-68 DSC MRI 5.3±0.9 2.5±0.4 2.1±na 
       
Vonken et al., 1999  41 / 0 40-86 DSC MRI 6.5±1.0 3.6±0.9 1.8±na 
       
Yamaguchi et al., 1986  17 / 5 26-64 PET 4.1±0.5 na na 
 
Table 4a. CBV (mL/100 g) ± SDs of the healthy human brain. GM=gray matter, 
WM=white matter, GM:WM=the ratio of GM to WM, M=males, F=females, na=data 
not available, DSC MRI= dynamic susceptibility contrast MRI, PET=positron emission 
tomography. 
 
 
 
 
Leenders et al, 1990; Herzog et al., 1996; Østergaard et al, 1996a; Nighoghossian et al, 
1997; Schreiber et al, 1998; Koshimoto et al, 1999; Vonken et al, 1999; Meltzer et al., 
2000; Wirestam et al, 2000; Hunsche et al, 2002) (Table 4b). 
The MTT in units of seconds in the GM ranges between 2.6 and 6.8, and in the 
WM between 3.2 and 7.8, the ratio of GM to WM being 0.8-1.1 (Østergaard et al, 1996a; 
Nighoghossian et al, 1997; Schreiber et al, 1998; Koshimoto et al, 1999; Vonken et al, 
1999; Hunsche et al, 2002) (Table 4c). 
Age-and gender-related changes in perfusion parameters and cerebral 
hemodynamics in general have been found to be as variable as the absolute values. No 
firm conclusions can therefore be made, especially in connection with gender-related 
changes. However, some patterns in the changes with age do emerge. The CBV, both in 
the GM and in the WM, either decrease (Leenders et al, 1990; Marchal et al., 1992;
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Reference   N Age Modality    
   M/N Years   GM WM GM:WM 
       
Herzog et al., 1996  20 / 7 26±4 PET 83±20 16±3 5.2±na 
       
Hunsche et al., 2002   7 / 3 57±13 DSC MRI na na 2.4±0.4 
       
Hunsche et al., 2002   7 / 3 57±13 FAIR na na 2.9±0.4 
       
Koshimoto et al.,   8 /11 25-73 DSC MRI 37.3±8.4 22±na 1.7±na 
1999       
Leenders et al., 1990  18/16 22-82 PET 52.1±11 20.3±3.7 2.6±na 
       
McHenry et al., 1978  15 / 0 20-36 Xe  77.6±10.4 18.2±2.7 4.3±na 
       
Meltzer et al., 2000   5 /13 29±7 PET 62±10 na na 
       
Naritomi et al., 1979  26/20 21-63 Xe  89.1±7.3 na na 
       
Nighoghossian et al.,   8 / 2 31-79 DSC MRI na na 2.4±na 
1997       
Pantano et al., 1984  19 / 8 19-76 PET 50.7±10.3 24.5±4.1 2.1±na 
       
Schreiber et al., 1998  13 / 0 24-68 DSC MRI 67.1±16.3 23.7±4.9 2.8±na 
       
Wirestam et al., 2000  25/19 42-88 DSC MRI 68±28 36±13 1.9±na 
       
Vonken et al., 1999  41 / 0 40-86 DSC MRI 66±20 34±11 1.9±na 
       
Yamaguchi et al.,  17 / 5 26-64 PET 42.4±7.8 na na 
1986       
Østergaard et al,1996   6 / 0 29±4 DSC MRI 58.9±na 22±na 2.7±na 
 
Table 4b. CBF (mL/100 g/min) ± SDs of the healthy human brain. GM=gray matter, 
WM=white matter, GM:WM= the ratio of GM to WM, M=males, F=females, na=data 
not available, DSC MRI= dynamic susceptibility contrast MRI, FAIR=flow-sensitive 
alternating inversion recovery, PET=positron emission tomography, Xe=133Xe inhalation 
methods. 
 37 
 
Reference   N Age Modality    
   M/N Years   GM WM GM:WM 
       
Hunsche et al., 2002   7 / 3 57±13 DSC MRI na na   0.9±0.1 
       
Koshimoto et al.,   8 /11 25-73 DSC MRI 6.8±1.3 7.8±1.1   0.8±na 
1999       
Nighoghossian et al.,   8 / 2 31-79 DSC MRI na na   1.1±na 
1997       
Schreiber et al., 1998  13 / 0 24-68 DSC MRI 4.7±0.8 5.4±1.1   0.9±na 
       
Vonken et al., 1999  41 / 0 40-86 DSC MRI 6.4±1.8 6.9±2.3   0.9±na 
       
Østergaard et al.,1996   6 / 0 29±4 DSC MRI 2.62±0.6 3.19±0.93   0.8±na 
 
Table 4c. MTT (seconds) ± SDs of the healthy human brain. GM=gray matter, 
WM=white matter, GM:WM=ratio GM versus WM, M=males, F=females, na=data not 
available, DSC MRI= dynamic susceptibility contrast MRI. 
 
 
 
 
Petrella et al, 1998; Koshimoto et al, 1999) or remain fairly constant (Yamaguchi et al, 
1986; Marchal et al, 1992; Koshimoto et al, 1999) with age. The same tendency has been 
seen in the CBF of the GM, the CBF either decreasing (Naritomi et al, 1979; Pantano et 
al, 1984; Leenders et al, 1990; Martin et al., 1991; Marchal et al, 1992; Krausz et al., 1998; 
Koshimoto et al, 1999; Wirestam et al, 2000) or remaining fairly constant (Fujishima and 
Omae, 1980; Yamaguchi et al, 1986; Waldemar et al., 1991; Meltzer et al, 2000). The CBF 
of the WM, by contrast, either remains fairly constant (Pantano et al, 1984; Leenders et al, 
1990; Marchal et al, 1992) or increases (Wirestam et al, 2000). The MTT has been the 
least studied parameter; however, it appears to increase with age (Fujishima and Omae, 
1980). 
 
 
IMAGING OF ISCHEMIC STROKE 
 
In DSC MRI, acute ischemic changes can be seen within minutes after induction of focal 
ischemia in experimental models (Hoehn et al, 2001). It is thought to be even more 
sensitive to these changes than DWI (Tong et al., 1998; Ueda et al., 1999b), to correlate 
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more closely with the acute neurological deficit (Tong et al, 1998), and to predict more 
accurately the size of final lesion (Fiehler et al., 2002c). Serial imaging with DSC MRI can 
document the evolution of perfusion lesion over time in experimental as well as in human 
studies (Barber et al, 1998; Beaulieu et al., 1999; Marks et al., 1999; Karonen et al., 2000). 
Perfusion deficit typically diminishes over time, in contrast to diffusion deficit (Barber et 
al, 1998). 
By combining DWI with DSC MRI, the diagnosis of acute stroke becomes more 
accurate (Warach et al., 1996; Baird and Warach, 1998; Fisher and Albers, 1999; Karonen 
et al., 1999; Sorensen et al., 1999a; Ueda et al., 1999a; Neumann-Haefelin et al., 2000a; 
Fiehler et al., 2001; Wittsack et al., 2002; Schellinger et al, 2003). Typically, an early 
perfusion lesion is larger than an early diffusion lesion, a phenomenon called diffusion-
perfusion mismatch (Baird et al., 1997; Barber et al, 1998; Rordorf et al., 1998; Tong et al, 
1998). However, other patterns of acute lesions can also be seen. A perfusion deficit may 
sometimes be smaller or equal to the diffusion deficit (Barber et al, 1998). Thus, early 
identification of the clinically relevant lesion and differentiation between various stroke 
types are feasible with the analysis of diffusion-perfusion lesion patterns (Darby et al., 
1999; Neumann-Haefelin et al, 2000a). DWI combined with DSC MRI facilitates the 
decision between management with and without thrombolytic therapy (Neumann-
Haefelin et al., 1999; Sunshine et al., 1999; Warach, 2001; Parsons et al., 2002; Schellinger 
et al, 2003), even after the three-hour time window for thrombolysis (Barber et al, 1998; 
Albers, 1999; Parsons et al, 2002; Röther et al, 2002; Schellinger et al, 2003). While the 
diffusion deficit represents the ischemic core, which reflects irreversible damage in most 
cases, the more extensive perfusion deficit typically represents the penumbra, in which 
the neurons are functionally silent but structurally intact and therefore potentially 
salvageable with recanalization (Albers, 1999; Parsons et al, 2002; Schellinger et al, 2003). 
However, chronic hypoperfusion due to CS in the setting of acute ischemia may 
erroneously be attributed to acute thrombosis and be regarded as tissue-at-risk 
(Neumann-Haefelin et al., 2000b). In such cases, MRA demonstrating a tight CS without 
intracranial arterial occlusions should raise the suspicion of a chronic hypoperfusive state. 
Studies of quantitative values for brain perfusion in ischemic lesions have been 
scarce and the results highly variable. Therefore, the relative values between the 
hypoperfused area and the normal-appearing contralateral region may be more reliable. 
The use of the contralateral region as a reference may, however, have limitations because 
of possible earlier ischemic or other lesions in these patients. Mean ratios for the ischemic 
lesion of the CBV have been found to vary between 0.69 and 0.89, of the CBF between 
0.12 and 0.29, and of the MTT between 1.82 and 2.31 (Schlaug et al., 1999; Hunsche et 
al, 2002). The regions of hypoperfusion seen on the MTT maps are larger than on other 
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maps (Ueda et al, 1999b), and the MTT map is considered to be the most sensitive 
parameter for detecting the ischemic penumbra. 
 
 
IMAGING OF CAROTID STENOSIS AND ENDARTERECTOMY 
 
CS and occlusion may compromise cerebral perfusion (Chaves et al., 2003; Kajimoto et 
al., 2003). However, the findings of several studies with different imaging methods (DSC 
MRI, PET, SPECT, 133Xe inhalation, and transcranial Doppler sonography) have varied 
markedly (Powers et al, 1987; Powers, 1991; Nighoghossian et al, 1994; Nighoghossian et 
al., 1996; Klijn et al, 1997; Derdeyn et al., 1998; Kluytmans et al., 1998b; Derdeyn et al, 
1999; Maeda et al., 1999; Lin et al., 2001; Derdeyn et al., 2002; Chaves et al, 2003; 
Vanninen et al., 2003). This might be due to variability in patient selection or differences 
in the ability of imaging methods to detect hemodynamic changes. Generally, the risk for 
stroke in patients with tight CS and occlusion is increased (Silvestrini et al, 1996; 
Yamauchi et al, 1996; Markus and Cullinane, 2001; Vernieri et al, 2001), but the role of 
the degree of stenosis in increasing the risk in the ACS patients is debatable (see above). 
CS or occlusion may interfere with the diffusion-perfusion mismatch of an acute 
stroke patient (Neumann-Haefelin et al, 2000b; Szabo et al, 2001). Proper management in 
such cases would depend on the suspicion of stenosis or occlusion behind the diffusion-
perfusion mismatch by the physician, and imaging with MRA. An acute stroke patient 
who does not benefit from thrombolytic therapy thus receives it in vain and is exposed to 
possible complications. 
When appropriately performed, CEA improves outcome of SCS patients, but its 
role in ASC is less beneficial, and its effect on cerebral hemodynamics over the long term 
is less clear. It seems to improve hemodynamic state, as suggested by postoperative 
improvement in CBF and cerebrovascular reactivity (Hartl et al, 1994; Vanninen et al, 
1995; Kluytmans et al, 1998a; Wiart et al, 2000; Markus and Cullinane, 2001; Rutgers et 
al, 2001; Vanninen et al, 2003). However, some findings suggest that differences exist in 
hemodynamics between these patient populations (Silvestrini et al, 1996; Derdeyn et al, 
1999), but heterogeneity in patient selection makes it difficult to draw definitive 
conclusions (Gillard et al., 1998). 
DSC MRI seems to be a reasonable imaging method for detecting the changes 
caused by CS, carotid occlusion, and CEA (Nighoghossian et al, 1996; Reith et al., 1997; 
Schreiber et al, 1998; Lythgoe et al., 2000; Apruzzese et al., 2001; Doerfler et al., 2001; 
Lin et al, 2001; van Osch et al., 2002; Chaves et al, 2003; Kajimoto et al, 2003). It may 
even be possible to receive absolute perfusion parameters of changes induced by these 
disease states and the operation. However, DSC MRI may be more useful and reliable in 
relative measures, as could be expected on the grounds of earlier discussion. 
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IMAGING OF LEUKOARAIOSIS 
 
As the primary hypothesis for the etiology of LA is chronic ischemia of the brain, PI 
appears to be a suitable tool for investigating this state. Studies of LA with DSC MRI are 
few, but some preliminary conclusions can be drawn. The CBF seems to be the most 
sensitive perfusion parameter for leukoaraiotic changes. It is consistently lower both in 
leukoaraiotic regions and in normal-appearing WM of subjects with LA than in healthy 
controls (Markus et al., 2000; O'Sullivan et al., 2002), supporting hypoperfusion and 
chronic ischemia being involved in the pathogenesis of LA. Findings in other perfusion 
parameters have, however, been more variable (Oppenheimer et al., 1995; Markus et al, 
2000). CS leading to hypoperfusion and thus to chronic ischemia of the brain has been 
suspected of inducing LA, and some studies support this expectation (Oppenheimer et al, 
1995; Yamauchi et al., 1999). However, DSC MRI on LA is still in its early days, and 
further studies are needed. 
 
 
IMAGING OF OTHER DISEASES 
 
DSC MRI detects changes in the microcirculation of brain tissue. Therefore, it is a 
suitable imaging method in studying diseases with disturbance in the cerebral circulation. 
Ischemic stroke is by far the most studied disease, but utility of DSC MRI in imaging 
other diseases, such as neoplasms (Cha et al, 2002), migraine (Cutrer et al., 1998; Sanchez 
del Rio et al., 1999), cerebral infections (Cha et al, 2002), and various dementias (Sandson 
et al., 1996; Alsop et al., 2000), has been reported. In neoplasms, DSC MRI may even 
preoperatively differentiate high- and low-grade tumors (Knopp et al., 1999), thus aiding 
in prognostic evaluation and management. It also seems to be useful in the study of MS, 
distinguishing active lesions from chronic ones (Haselhorst et al., 2000). As the 
methodology develops, DSC MRI may become a more attractive imaging method in 
studying various diseases of the brain, as it has the potential to provide physiologic 
information to complement the anatomic information provided by conventional MRI. 
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AIMS OF THE STUDY 
 
 
 
The purpose of this thesis was to test the feasibility of DWI and DSC MRI in studying 
the healthy human brain and in detecting changes induced by ischemic stroke, CS, CEA, 
and LA. The more detailed aims were: 
 
1. To evaluate whether ADCav values, CBV, CBF, and MTT in selected regions of the 
healthy human brain differ with age, gender, or hemisphere, and to establish reference 
values for further studies of DWI and DSC MRI (Studies I and II). 
 
2. To investigate ADCav values, CBV, CBF, and MTT before CEA, and 3 and 100 days 
afterwards to determine whether these values differ between hemispheres over time, and 
in ASC and SCS patient groups (Studies III and IV). 
 
3. To assess whether ADCav values of leukoaraiotic regions or normal-appearing WM 
vary according to the severity of LA, and whether these values can be used to distinguish 
leukoaraiotic regions from normal-appearing WM and from ischemic strokes of various 
ages (Study V). 
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SUBJECTS AND METHODS 
 
 
 
SUBJECT CHARACTERISTICS 
 
The Ethics Committees of the Departments of Neurology and Radiology at Helsinki 
University Central Hospital approved all study protocols. Principles of the Declaration of 
Helsinki and institutional guidelines were followed. The subjects provided written 
informed consent before enrollment, after which they underwent thorough clinical 
assessment and detailed questioning regarding any symptoms. Those for whom MRI was 
contraindicated (Shellock et al, 1993) were excluded. 
 
 
HEALTHY SUBJECTS 
 
Eighty volunteer subjects (40 males and 40 females) were chosen from a healthy adult 
population of the Helsinki region. They were 22 to 85 years of age, with a mean age of 
50.0±17.4 years in Study I, and 49.9±17.4 years in Study II [49.9±17.2 (49.8±17.1), range 
22-85 years for males and 50.1±17.9, range 22-82 years for females]. Their age 
distribution was uniform within each of the four age groups (10 males and 10 females per 
group): Group I: 20 to 34 years (mean 26.8±4.1, range 22-34 years), Group II: 35 to 49 
years (mean 43.6±4.4, range 36-49 years), Group III: 50 to 64 years [mean 57.4±3.5 
(57.3±3.8), range 52-64 (51-64) years], and Group IV: 65+ years (mean 72.2±5.2 
(72.1±5.3), range 65-85 years]. Eight of the volunteers were left-handed, and 72 were 
right-handed. 
None of the subjects had symptoms, signs, or history of any neurological or 
systemic disease that might have affected the brain (e.g. diabetes, chronic obstructive 
pulmonary disease, hypertension, or metabolic disorders), nor did they have a family 
history of dementia or MS. None was taking medication regularly, except for female 
hormones for replacement therapy or topical drugs. Subjects in whom MRI revealed an 
unexpected cerebral lesion (one meningeoma and one arteriovenous malformation) were 
excluded. WM changes (n=22, 16 in Group IV, and 6 in Group III) found in the 
conventional MR images of older subjects were regarded as a part of normal aging. All of 
the subjects were white and all except two were of Finnish origin. 
In Study III, 45 individuals (28 males, aged 59.1±11.1, range 42-85 years, and 17 
females, aged 66.9±8.5, range 52-82 years) with or without LA, and in Study V, 22 
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individuals (12 males, aged 59.9±6.3, range 52-70 years, and 10 females, aged 60.7±6.9, 
range 52-73 years) without LA on conventional MR images were chosen from the 80 
healthy subjects described above for the comparative analyses. 
 
 
ISCHEMIC STROKE PATIENTS 
 
Ten acute ischemic stroke patients (5 males, aged 64.4±17.9, range 48-88 years, and 5 
females, aged 73.8±4.6, range 67-78 years) without thrombolytic therapy were serially 
imaged less than 6 hours (mean 4.4±1.0, range 2.7-5.9 hours, n=10), 24 hours (mean 
28±2.7, range 23.8-31 hours, n=10), one week (mean 6.6±0.6, range 5.8-7.3 days, n=10), 
one month (mean 33±2.9, range 30-36 days, n=4), and 3 months (mean 90±5.8, range 
80-95 days, n=6) after the insult. The mean infarct volume measured on the one-week 
images was 16.2±19 cm3. Four of the infarcts were cortical and six were subcortical. 
According to the TOAST criteria (Adams et al, 1993), four of the infarcts were due to 
atherosclerosis, three were cardioembolic, two were caused by small vessel disease, and in 
one patient the etiology could not be determined. Five of them were left-sided and five 
right-sided. 
 
 
CAROTID STENOSIS AND ENDARTERECTOMY PATIENTS 
 
Studies III and IV were conducted as part of the larger Helsinki Carotid Endarterectomy 
Study, which included 102 patients with high-grade CS. The patients of these two studies 
were independent in their daily lives (modified Rankin scale < 2). They did not have 
emboli of cardiogenic origin or a history of previous CEA or radiotherapy for the neck or 
cervical region. They had a surgically accessible unilateral CS measuring 70% or more in 
digital subtraction angiography according to the NASCET criteria (North American 
Symptomatic Carotid Endarterectomy Trial, 1991). Due to artifacts in ADCav (n=2) or 
perfusion (n=2) maps, minor differences exist between patient populations of Studies III 
(n=45) and IV (n=46). 
Of the 46 (45) [29 (28) males, 17 females] patients (mean age 64.6±8.6, range 48-
78 years), 23 (22) [12 (11) males, 11 females; 65.0±8.6 (65.6±8.3), range 52-78 years] were 
asymptomatic, and 23 [17 males, 6 females; mean age 63.2±9.1 (63.7±9.0), range 48-78 
years] had had recent cerebrovascular symptoms (average 39 days) ascribed to the 
territory of the stenotic artery. In the asymptomatic group, stenosis was on average 
77±7.6%, and in the symptomatic group 80±10.9%, as measured from digital subtraction 
carotid artery angiograms by an experienced neuroradiologist (OS) blinded to the clinical
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    ACS SCS p value 
     
Age (years) 65.0±8.6 63.2±9.1 0.53 
Degree of CS (%) 77±7.8  80±10.9  0.33 
Cerebrovascular events:    
 Stroke 0 11  
 TIA 0 12  
Gender (males/females)  12 / 11   17 / 6  0.22 
Arterial hypertension 14 16 0.56 
Coronary heart disease 12 9 0.39 
Diabetes  4 8 0.44 
Peripheral arterial disease 9 7 0.59 
Smoking     
 Never 3 4  
 former    15 13  
 Current 5 6 0.78 
Blood viscosity (fibr x(hcr)3) 0.24±0.07 0.28±0.08 0.04 
Total cholesterol (mmol/L) 5.3±1.1 5.3±1.1 0.90 
Triglycerides (mmol/L) 1.7±0.9 1.6±0.8 0.64 
Anticoagulation 4 10 0.10 
Antiaggregation 16 12 0.58  
 
Table 5. Demographic and risk factor profiles of ACS and SCS patients (±SD). For 
clarity, only profiles of subgroups of Study IV are included. 
 
 
 
data. None of the patients had significant stenoses in intracranial arteries. Demographic 
and risk factor profiles were uniform in ACS and SCS patient groups (Table 5). 
The first imaging was performed in the evening of the preoperative day, and the 
scanning was repeated at three days (postoperative) (n=42) and 100 days (chronic) (n=37) 
after CEA. Ipsilateral silent lacunar infarcts were detected in two (three) ACS patients. In 
the SCS group, relevant infarcts were detected in 11 patients. As perioperative 
complications, three patients had new minor brain infarcts, and one had an asymptomatic 
intracerebral hemorrhage. All infarcts and the intracerebral hemorrhage were detected on 
DWI, T2*-weighted, and conventional MR images by an experienced neuroradiologist. 
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SUBJECTS WITH LEUKOARAIOSIS 
 
In the imaging studies of healthy subjects, ischemic stroke patients, and CS patients, 
altogether 85 subjects with LA were identified. Twenty-two of these were healthy (9 
males, aged 71.2±6.7, range 62-85 years, and 13 females, aged 66.5±11.0, range 42-82 
years), 53 were either unilateral or bilateral CS patients (33 males, aged 64.0±8.9, range 
47-77 years, and 20 females, aged 65.1±7.8, range 52-77 years), and 10 were the acute 
ischemic stroke patients described above. 
 
 
METHODS 
 
IMAGING TECHNIQUES 
 
All studies were performed with a Siemens Magnetom Vision imager (Siemens Medical 
Systems, Erlangen, Germany) operating at 1.5 T. A standard head coil was used. Axial 
DW images, DSC MRI, fluid-attenuated inversion recovery, T1-weighted, T2-weighted, 
and proton density-weighted imaging as well as MRA were obtained. All imaging studies 
were completed without adverse events or complications. In the studies of healthy 
subjects (Studies I and II), however, due to malfunction of the imager (n=3) or artifacts 
in perfusion images (n=2), extra imaging sessions had to be arranged. 
 
 
DIFFUSION-WEIGHTED IMAGING 
 
DWI was performed with a SE EPI sequence that had a TR of 4000 ms, an TE of 103 
ms, and a gradient strength of 25 mT/m covering 19 five-mm-thick slices (interslice gap 
1.5 mm, field of view (FOV) 230x230 mm2, and matrix size 96*128 interpolated to 
256*256). Diffusion was measured in three orthogonal directions (x, y, and z) with two b 
values (b=0 and b=1000 s/mm2). 
 
 
DYNAMIC SUSCEPTIBILITY CONTRAST IMAGING 
 
In Study II, DSC MRI was performed with a lipid-suppressed SE EPI sequence (TR 
1500 ms, TE 78 ms, FOV 230x230 mm2, matrix size 96*128) covering 7 five-mm-thick 
slices with an interslice gap of 1.5 mm. The seven slices were imaged 40 times at 1.5-
second intervals. 
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In Study IV, a GE EPI sequence (TR 1.2 ms, TE 42.1 ms, FOV 230x230 mm2, 
matrix size 96*128) covering 5 five-mm-thick slices with an interslice gap of 1.5 mm was 
used. The five slices were imaged 60 times at 1.5-second intervals. 
After the collection of seven baseline images, Gd-DTPA (Magnevist, Schering 
AG, Berlin, Germany) 0.2 mmol/kg (Study II) or 0.15 mmol/kg (Study IV) was injected 
into the antecubital vein using an 18-gauge catheter. The injection was performed at a 
speed of 5 mL/s using an MR-compatible power injector (Spectris, Medrad, Pittsburg, 
PA, USA). The bolus of Gd-DTPA was followed by a 10-mL bolus of saline at the same 
injection rate to flush the remaining contrast agent into the bloodstream. The intravenous 
line was kept open until the actual injection by flushing it with saline at a rate of 0.25 
mL/min. 
 
 
DATA ANALYSES 
 
DIFFUSION-WEIGHTED IMAGING 
 
After the imaging session, the DW images were transferred to a separate workstation for 
calculation of the ADCav maps. The calculation was performed with a commercially 
available software program (MatLab, Mathsoft Inc., Natick, MA, USA). First, the DW 
images in the three orthogonal directions were co-registered. Then, natural logarithms of 
the images were averaged to form a rotationally invariant resultant image. Using a linear 
least-square regression on a pixel-by-pixel basis, the resultant image and the natural 
logarithm of the reference T2-weighted image were fitted to the b values (b=0 and 
b=1000). The negative slope of the fitted line was the ADCav (Figure 1). 
 
 
DYNAMIC SUSCEPTIBILITY CONTRAST IMAGING 
 
The postprocessing of the perfusion data was also performed on a separate 
workstation. Spatial filtering was performed on the raw images by a 3-by-3 pixel uniform 
smoothing kernel before the calculation of the perfusion maps. Tissue and arterial 
concentration levels were determined from the perfusion raw images assuming a linear 
relationship between intravascular concentration of Gd-DTPA and the change in 
transverse relaxation rate (Fisel et al., 1991; Weisskoff et al., 1994): 
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0
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where C(t) is the tissue concentration-time curve, ∆R2 is the change in transverse 
relaxation rate, TE is the echo time, S0 is the baseline signal intensity, and S(t) is the tissue 
signal intensity with Gd-DTPA present (Belliveau et al, 1990; Østergaard et al, 1996a). T1 
was assumed to be unchanged during the bolus injection (Østergaard et al, 1996a). Then, 
the CBV, CBF, and MTT (Figure 2) were determined from the concentration curves on a 
pixel-by-pixel basis. 
For the calculation of the CBV, the area under the first pass of the tissue 
concentration-time curve was determined on a pixel-by-pixel basis using numerical 
integration (Perkiö et al, 2002). The lower and upper limits of the integration of the tissue 
concentration time were determined based on inspection of the whole brain 
concentration-time curve, i.e. the first pass of the Gd-DTPA bolus was set to begin and 
end at the same time for all pixels. For quantification purposes, an AIF was determined 
from 2-5 pixels located in small vessels supplied by the MCA (Østergaard, 1998). CBV 
was determined as the area under the first pass of the tissue concentration-time curve 
normalized with the area of the AIF and the injected dose of Gd-DTPA (Rosen et al, 
1991) and taking into account the hematocrit difference of 2/3 between the micro- and 
macrovasculature (Østergaard et al, 1998b). 
For the calculation of the CBF, the tissue concentration-time curve was first 
deconvolved with the AIF by singular value decomposition to determine the tissue 
impulse response functions on a pixel-by-pixel basis. Then, the CBF was determined as 
the height of the deconvolved tissue impulse response (Østergaard et al, 1996b). 
For the calculation of the MTT in units of seconds, the ratio CBV:CBF was 
determined (Meier and Zierler, 1954; Stewart, 1984). 
 
 
RATING SCALE FOR LEUKOARAIOSIS 
 
T2-weighted, proton density-weighted, and fluid-attenuated inversion recovery images 
were evaluated for leukoaraiotic regions according to a previously validated rating scale 
(Mäntylä et al, 1999a) by a neuroradiologist blinded to subjects’ clinical data. Ischemic 
and other lesions were also evaluated. Subjects with unexpected cerebral lesions 
(meningioma, n=1, and arteriovenous malformation, n=1) were excluded from the 
studies of healthy subjects (Studies I and II). 
Periventricular hyperintensities (PVH) were classified based on size and shape 
into the following three groups: PVH 1 (small cap/thin lining, <5 mm, n=47), PVH 2 
(large cap/smooth halo, 6 to 10 mm, n=22), and PVH 3 (extending cap/irregular halo, 
>10 mm, n=16). 
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Figure 1. ADCav map of a male subject with LA. Note that leukoaraiotic regions and 
CSF are hyperintense. In DW images, the same regions are hypointense. 
 
 
 
 
 
Figure 2. CBV, CBF, and MTT maps of a healthy female. 
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  Hyperintensities (HI), the WM lesions situated far from the periventricular area, 
were classified into five groups: HI 1 (small focal, <5 mm, n=41), HI 2 (large focal, 6 to 
10 mm, n=25), HI 3 (focal confluent, 11 to 25 mm, n=13), HI 4 (diffusely confluent, 
>25 mm, n=6), and HI 5 (diffuse lesions affecting most of the WM area, n=0). 
 
 
 
REGION OF INTEREST (ROI) ANALYSIS 
 
The ROI analysis varied slightly between studies due to differences in imaging methods 
(DWI and DSC MRI) or patient groups (healthy volunteers and patients with cerebral 
lesions) used. The following was, however, uniform in all studies: ROIs were manually 
drawn on their respective maps after the lesions were carefully analyzed on the 
conventional images. The surface area was measured in pixels, and the mean, standard 
deviation (SD), and range of the given values were obtained. The ROI analysis was 
performed with a commercially available image analysis software (Alice, Hayden Image 
Processing Group, Perceptive Systems Inc., Boulder, CO, USA). 
In healthy subjects and in CS patients, 20 to 36 distinct structures – the exact 
number of structures depending on the imaging method (DWI and DSC MRI) or the 
given study (healthy subjects or CS patients) – were selected for the analysis. These 
structures were the frontal, parietal, temporal, occipital, and cerebellar GM and WM, 
watershed regions (WsR) between the territories of MCA and ACA or MCA and PCA, 
the caudate nucleus, putamen, thalamus, internal capsule, pons, and the CSF in lateral 
ventricles (frontal horn, middle part, posterior horn). Special care was taken to avoid 
contamination of normal-appearing WM ROIs with the regions of LA, ischemic lesions, 
or CSF. 
In ischemic stroke patients, 2 to 6 ROIs covering the ischemic lesions, 8 to 14 
ROIs of the leukoaraiotic regions, and 4 normal-appearing WM ROIs from the frontal 
and occipital lobes were analyzed. 
In the analysis of LA subjects, 8 to 14 ROIs of leukoaraiotic regions were selected 
from both hemispheres covering the entire surface area of LA in the brain, and compared 
with 4 ROIs of the normal-appearing WM from the frontal and occipital lobes. 
In addition to the ROI analysis, the baseline and postoperative MTT maps of 
Study IV were analyzed visually for the presence of a perfusion deficit. 
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STATISTICAL ANALYSES 
 
 
The normality of distributions was tested with Shapiro-Wilk’s test. In Studies I-IV, the 
values were normally distributed and therefore parametric tests were used. 
Interhemispheric and regional variation in healthy subjects and in CS patients as well as 
the comparison between ACS and SCS patient groups were studied with one-way or two-
way and repeated-measures analyses of variance (or covariance), as appropriate, using 
symptomaticity (Studies III and IV) as the between-subjects variable. Comparison 
between the groups representing different age cohorts and different genders was 
performed using multivariate analysis of variance or covariance, with within-subject and 
between-subjects designs, as appropriate. Bivariate regression analysis was used to further 
test age dependence (Studies I and II). Pairwise comparisons were made with Student’s t 
test, either for independent or dependent samples, as appropriate. The univariate results 
were corrected for multiple comparisons. Chi-square test or Fisher’s exact test was 
applied to univariate dichotomous variables. The homogeneity of the variances was 
studied using Box M test or Levene’s test, sphericity was evaluated with Greenhouse-
Geisser values, and the Scheffé test was applied for post-hoc comparisons. Correlations 
were studied with Pearson’s product-moment correlation or Spearman’s rank correlation, 
as appropriate. 
Since ADCav values and group sizes in Study V deviated significantly from normal 
distribution, nonparametric tests were used. The ADCav values of LA, ischemic stroke, 
and normal-appearing WM were compared using Kruskal-Wallis one-way analysis of 
variance, as were the groups of varying degrees of LA and stroke. Groupwise comparison 
between any two groups was made using the Mann-Whitney U test. 
The values are given as means ± SDs and 95% confidence intervals. A two-tailed 
value of p<0.05 was considered to be significant. 
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RESULTS 
 
 
 
DIFFUSION-WEIGHTED IMAGING 
 
All ADCav values are given as x10-3 mm2/s. The values are means ± SDs and (95% 
confidence intervals) in the text, and means ± SDs or (95% confidence intervals) in the 
tables and figures. 
 
 
HEALTHY BRAIN 
 
For the whole brain of all healthy subjects (n=80), the mean ADCav values were 
0.89±0.04 (0.88-0.90) for the cortical GM, 0.70±0.03 (0.69-0.71) for the WM vs. 
0.63±0.02 (0.63-0.64) for the WM of the subjects in Study III (n=45), 0.65±0.04 (0.64-
0.66) for the WsR (n=45), 0.75±0.03 (0.74-0.75) for the basal ganglia, 0.73±0.03 (0.73-
0.74) for the thalamus, 0.51±0.07 (0.50-0.53) for the internal capsule, 0.60±0.06 (0.59-
0.62) for the pons, 0.82±0.11 (0.79-0.84) for the cerebellar GM, 0.59±0.05 (0.58-0.60) for 
the cerebellar WM, and 2.86±0.22 (2.8-2.9) for the lateral ventricles. More detailed values 
for various age groups and for males and females separately are presented in Table 6. 
The ADCav values of the cortical GM were consistently higher than those of the 
WM in all subjects (p<0.001) and in all subgroups (p<0.001). The ADCav values of the 
basal ganglia and thalamus were higher than those of the WM (p<0.001) but lower than 
those of the cortical GM (p<0.001) (Table 6). The ADCav values of the WM in the brain 
lobes did not differ from each other in Study I subjects. However, the ADCav values of 
the frontal WM were higher than those of the other three lobes in Study III subjects, 
since the ROI analysis in this study slightly differed from that of Study I. No significant 
differences were found in the lobular GM ADCav values or between the hemispheres, 
except in the cerebellar GM, where the left hemisphere had ADCav values of 0.84±0.12 
(0.81-0.86) and the right 0.80±0.14 (0.77-0.83) (p<0.02). 
The ADCav values of the lateral ventricles increased with age (p<0.001) (Table 6). 
The homogeneity of the variances was normal in all of the other brain regions, except in 
the thalami (p<0.002 for the left and p<0.001 for the right thalamus), where the ADCav 
values in Group IV were significantly higher than in the other age groups (Table 6). No 
other age-related changes were found (Figure 3). 
No differences were observed between males and females in any region of the 
brain (Figure 3 and Table 6). 
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             Genders          Age Groups  
ROI All Males Females I II III IV 
        
GM 0.89±0.04 0.89±0.03 0.89±0.05 0.90±0.03 0.89±0.04 0.90±0.06 0.89±0.03 
        
WM 0.70±0.03 0.70±0.03 0.71±0.03 0.70±0.02 0.70±0.04 0.70±0.03 0.71±0.04 
        
BG 0.75±0.03 0.75±0.03 0.75±0.04 0.74±0.03 0.74±0.02 0.75±0.03 0.76±0.04 
        
TH 0.73±0.03 0.73±0.03 0.74±0.03 0.73±0.02 0.72±0.03 0.73±0.03 0.76±0.05 
        
IC 0.51±0.07 0.51±0.07 0.52±0.06 0.52±0.06 0.50±0.08 0.51±0.07 0.53±0.06 
        
PO 0.60±0.06 0.60±0.06 0.60±0.06 0.61±0.07 0.57±0.04 0.62±0.05 0.60±0.07 
        
CG 0.82±0.11 0.80±0.11 0.83±0.11 0.80±0.10 0.78±0.12 0.85±0.12 0.83±0.10 
        
CW 0.59±0.05 0.59±0.05 0.59±0.06 0.60±0.04 0.59±0.06 0.59±0.07 0.59±0.04 
        
CS 2.86±0.22 2.86±0.20 2.87±0.24 2.78±0.22 2.78±0.21 2.88±0.20 3.01±0.16 
 
Table 6. ADCav values (x10-3 mm2/s) ± SDs of healthy subjects for males and females 
and for age groups. GM=gray matter, WM=white matter, BG=basal ganglia, 
TH=thalamus, PO=pons, IC=internal capsule, CG=cerebellar gray matter, 
CW=cerebellar white matter, CS=cerebrospinal fluid in lateral ventricles. 
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Figure 3. ADCav values (x10-3 mm2/s) ± SDs of gray and white matter of the healthy 
brain in age groups I to IV and in males and females separately. Squares=gray matter, and 
triangles=white matter. 
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Figure 4. Stroke ADCav values (x10-3 mm2/s) ± SDs from the hyperacute to the chronic 
phase. 
 
 
 
 
 
ISCHEMIC STROKE 
 
The ADCav values of the ischemic stroke lesions were 0.38±0.08 (0.33-0.44) at 
hyperacute stage, 0.36±0.08 (0.31-0.42) at 24-hour stage, and 0.51±0.09 (0.45-0.57) at 
one-week stage (n=10 for each imaging time). At one month, the ADCav values of the 
ischemic lesions were 1.08±0.33 (0.56-1.60) (n=4) and at chronic stage 1.59±0.32 (1.26-
1.93) (n=6) (Figure 4). 
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  All ACS SCS  All ACS SCS 
Gray Matter    Thalamus   
Stenotic    Stenotic   
Preoperative 0.91±0.03 0.90±0.03 0.92±0.03  0.76±0.06 0.75±0.06 0.77±0.06 
        
Postoperative 0.90±0.03 0.89±0.03 0.90±0.03  0.77±0.06 0.76±0.06 0.78±0.07 
        
Chronic 0.90±0.03 0.89±0.03 0.90±0.03  0.76±0.06 0.74±0.06 0.77±0.06 
Contralateral    Contralateral  
Preoperative 0.90±0.03 0.90±0.02 0.90±0.03  0.77±0.07 0.76±0.07 0.77±0.06 
        
Postoperative 0.89±0.03 0.88±0.02 0.89±0.03  0.76±0.06 0.75±0.06 0.76±0.06 
        
Chronic 0.89±0.03 0.88±0.02 0.90±0.03  0.76±0.07 0.73±0.05 0.78±0.09 
White Matter    Watershed   
Stenotic    Stenotic   
Preoperative 0.69±0.04 0.69±0.04 0.69±0.04  0.74±0.05 0.73±0.05 0.74±0.05 
        
Postoperative 0.67±0.04 0.67±0.04 0.68±0.04  0.70±0.05 0.70±0.04 0.70±0.06 
        
Chronic 0.67±0.04 0.66±0.03 0.67±0.04  0.69±0.05 0.68±0.04 0.70±0.06 
Contralateral    Contralateral  
Preoperative 0.65±0.04 0.66±0.04 0.65±0.03  0.70±0.04 0.70±0.05 0.70±0.04 
        
Postoperative 0.67±0.04 0.67±0.04 0.67±0.04  0.70±0.06 0.71±0.06 0.69±0.06 
          
Chronic 0.67±0.04 0.67±0.04 0.67±0.04  0.69±0.06 0.71±0.06 0.68±0.06 
 
Table 7. ADCav values (x10-3 mm2/s) ± SDs of CS patients for ACS and SCS patient 
groups separately at three imaging stages. ACS=asymptomatic carotid stenosis, 
SCS=symptomatic carotid stenosis. 
 
 
 
CAROTID STENOSIS AND ENDARTERECTOMY 
 
Preoperatively, the ADCav values of the WM and the WsR in the lobes of the hemisphere 
ipsilateral to the CS were higher than those of the contralateral side (p<0.001). Such an 
asymmetry was not detected in the GM (p=0.2) or the thalamus (p=0.8) (Table 7). 
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Figure 5. Lobular WM ADCav values (x10-3 mm2/s) ± 95% confidence intervals of 
ipsilateral and contralateral sides compared with lobular WM ADCav values of control 
subjects. Squares=ipsilateral means, triangles=contralateral means, and circles=control 
means. 
 
 
 
At the postoperative and chronic stages, the ipsilateral WM and WsR had 
resumed lower ADCav levels that were not significantly different from those of the 
contralateral hemisphere (postoperatively, WM: p=0.5 and WsR: p=0.9; at the chronic 
stage, WM: p=0.5 and WsR: p=0.4) (Table 7). 
In comparing ACS and SCS patient groups, no significant differences were found, 
although SCS patients tended to have slightly higher ADCav values in the WM and WsR 
(Table 7). 
The lobar ADCav values in the WM were different in each of at the three imaging 
stages. At the preoperative stage, the frontal and parietal lobes displayed higher values 
than the occipital and temporal (p<0.05) (Figure 5). The lobar differences at the 
postoperative and chronic stages persisted. 
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              Leukoaraiosis  NAWM 
 All Subjects Healthy  CS Stroke  All Subjects 
    Volunteers Patients Patients    
       
PVH 1 0.92±0.04 0.95±0.03 0.91±0.04 0.91±0.01  0.69±0.03 
       
PVH 2 0.99±0.08 0.93±0.04 1.02±0.08 1.06±0.00  0.69±0.04 
       
PVH 3 1.16±0.13 1.15±0.13 1.13±0.17 1.21±0.08  0.74±0.02 
       
HI 1 0.92±0.04 0.92±0.04 0.92±0.04 0.91±0.01  0.69±0.04 
       
HI 2 0.97±0.08 0.98±0.07 0.96±0.09 na  0.70±0.04 
       
HI 3 1.09±0.10 1.05±0.12 1.10±0.11 1.11±0.07  0.72±0.04 
       
HI 4 1.27±0.04 1.28±0.07 1.31±0.00 1.26±0.01  0.74±0.02 
 
Table 8. ADCav values (x10-3 mm2/s) ± SDs of the leukoaraiotic regions and the normal-
appearing WM in subjects with LA. CS=carotid stenosis, PVH=periventricular 
hyperintensity, HI=hyperintensity, NAWM=normal-appearing WM, na=data not 
available. 
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Figure 6. ADCav values (x10-3 mm2/s) ± SDs in the regions of leukoaraiosis and normal-
appearing WM in PVH 1 to 3 and HI 1 to 4. Squares=leukoaraiosis and tringles=white 
matter. 
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LEUKOARAIOSIS  
 
As the severity of LA increased from PVH 1 to PVH 3, and from HI 1 to 4, the ADCav 
values of both the leukoaraiotic regions and the normal-appearing WM showed a directly 
proportional increase (p<0.01 for both PVH and HI) (Table 8, and Figure 6).   
The regions of LA showed significantly higher ADCav values than the normal-
appearing WM in all subgroups (healthy subjects, CS patients, and ischemic stroke 
patients) (p<0.01 for each) (Table 8). 
The surface area of the regions of LA in unilateral CS patients was slightly larger 
in the ipsilateral than in the contralateral hemisphere (p<0.04), but the ADCav values of 
these regions were not different between hemispheres (0.95±0.12 vs. 0.95±0.11, p=1.0). 
 
 
 
COMPARISONS BETWEEN GROUPS 
 
Healthy controls had lower ADCav values in the WM and the WsR than CS patients in 
their preoperative ipsilateral WM and WsR (p<0.001), whereas no difference was 
detected in the GM or the thalamus. Despite the higher ADCav levels of CS patients, the 
relative differences between various brain lobes in their WM were identical to those of 
controls (Figure 5). The ADCav values of the anterior WsR were higher than the posterior 
WsR, on both the ipsilateral (0.76±0.05 vs. 0.71±0.07; p<0.001) and the contralateral 
(0.73±0.05 vs. 0.67±0.06; p<0.001) sides, and in controls (0.66±0.04 vs. 0.64±0.04; 
p<0.01). In the period following the operation, the ADCav values decreased considerably, 
but nonetheless remained significantly higher among patients than controls for the WM 
and the WsR (p<0.001). 
Overall, the ADCav values of the normal-appearing WM of subjects with LA did 
not significantly differ from those of healthy subjects with no LA. However, with more 
detailed analysis within the subject group with LA, the ADCav values of the normal-
appearing WM were found to vary according to the severity of LA, being highest in the 
most severe LA patient groups (p<0.01 for all) (Figure 6). 
At hyperacute stage, 24-hour stage, and one-week stage, the ADCav values of 
ischemic lesions were lower than those of the leukoaraiotic lesions (p<0.01 for all). At 
one month, the ischemic lesions showed similar ADCav values to those of the regions of 
LA. At chronic stage, by contrast, the ischemic lesions had significantly higher ADCav 
values than the regions of LA (p<0.01). 
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DYNAMIC SUSCEPTIBILITY CONTRAST IMAGING 
 
 
The values given are means ± SDs and (95% confidence intervals) in the text, and means 
± SDs or (95% confidence intervals) in the tables and figures. 
 
 
 
HEALTHY BRAIN 
 
 
For the analyzed regions of healthy subjects, the cortical GM showed the following 
perfusion values: CBV (4.6±1.0, 4.3-4.8 mL/100 g), CBF (94.2±23.0, 89.1-99.3 mL/100 
g/min), and MTT (3.0±0.6, 2.8-3.1 s), and the cortical WM: CBV (1.3±0.4, 1.2-1.4 
mL/100 g), CBF (19.6±5.8, 18.3-20.8 mL/100 g/min), and MTT (4.3±0.7, 4.2-4.5 s). 
More detailed analyses can be found in Tables 9a-c. 
No differences between hemispheres were found in any perfusion parameter. 
However, differences between brain lobes were found in all three perfusion parameters 
(p<0.02), the temporal lobes having the highest perfusion rates. The cortical GM had the 
highest perfusion rate, followed by the deep GM and the WM (p<0.01). The caudate 
nucleus showed higher CBV and CBF than the thalamus (p<0.01). No difference 
between the caudate nucleus and the thalamus was found in the MTT (Tables 9a-c). 
Generally, no change with age was found in any perfusion parameter, except for 
an increase in the MTT of the frontal and parietal GM (p<0.02). Although not 
significant, a tendency for an increase was also found in the mean GM MTT and CBV 
(Tables 9a-c, and Figures 7a-c). 
Males had higher CBV and MTT in the cortical and in the deep GM than females 
(p<0.04). In the WM, the MTT was also higher in males than in females (p<0.03), but no 
difference was detected in the CBV of the WM. No differences between genders were 
found in the CBF in any region (Tables 9a-c, and Figures 7a-c). 
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           Gender       Age Groups  
ROIs   All  Males Females I II III IV 
GRAY MATTER         
Frontal 4.2±1.0  4.5±1.0 3.9±0.9 * 3.9±1.0 4.0±0.9 4.3±0.9 4.6±1.1 
          
Occipital 4.5±1.1  4.9±1.1 4.2±1.1 * 4.5±1.2 4.4±1.2 4.8±1.2 4.6±1.0 
          
Temporal 5.1±1.3  5.6±1.4 4.6±1.0 * 4.8±1.3 4.7±1.0 5.5±1.2 5.4±1.6 
          
Parietal 4.4±1.1  4.8±1.1 3.9±0.9 * 4.1±1.0 4.3±0.9 4.5±1.2 4.6±1.2 
WHITE MATTER         
Frontal 1.4±0.4  1.5±0.5 1.4±0.3  1.2±0.4 1.3±0.4 1.6±0.5 1.6±0.4 
          
Occipital 1.4±0.6  1.5±0.6 1.4±0.5  1.2±0.4 1.3±0.4 1.7±0.6 1.5±0.7 
          
Temporal 1.5±0.7  1.6±0.8 1.3±0.5  1.5±0.7 1.4±0.7 1.4±0.7 1.5±0.8 
          
Parietal 1.0±0.4  1.1±0.4 0.9±0.3  0.9±0.3 1.0±0.3 1.2±0.5 1.0±0.4 
DEEP GRAY MATTER        
Caudatus 4.2±1.1  4.4±1.3 4.0±0.9 * 3.9±1.1 3.8±0.9 4.2±1.0 4.8±1.3 
          
Thalamus 3.9±1.1  4.2±1.1 3.5±0.9 * 3.4±0.8 3.5±1.1 4.2±1.0 4.3±1.2 
MEAN VALUES         
Gray Matter 4.6±1.0  4.9±1.0 4.2±0.8 * 4.3±1.0 4.3±0.9 4.8±1.0 4.8±1.1 
          
White Matter 1.3±0.4  1.4±0.5 1.2±0.3  1.2±0.3 1.3±0.3 1.5±0.5 1.4±0.4 
 
 
Table 9a. CBV (mL/100 g) ± SDs of all subjects for genders and age groups separately. 
Significant findings between subgroups have been marked with asterisks. 
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           Gender       Age Groups  
ROIs   All   Males Females I II III IV 
GRAY MATTER         
Frontal 89±24  91±27 86±19  93±28 83±23 91±25 88±18 
          
Occipital 93±24  94±26 91±23  98±29 86±20 95±27 91±19 
          
Temporal 105±28  109±32 101±24  109±31 96±20 111±33 105±26 
          
Parietal 90±24  94±27 86±19  95±27 88±18 91±29 87±19 
WHITE MATTER         
Frontal 23±8  23±9 23±6  20±6 21±7 25±9 24±6 
          
Occipital 20±8  20±9 20±7  17±7 18±6 24±9 20±9 
          
Temporal 21±9  22±10 20±7  21±10 20±6 22±9 21±9 
          
Parietal 15±6  15±7 15±6  14±5 14±6 18±8 15±5 
DEEP GRAY MATTER        
Caudatus 94±29  95±34 93±23  99±36 87±25 93±31 97±24 
          
Thalamus 84±22  85±24 83±21  83±23 78±20 89±28 88±17 
MEAN VALUES         
Gray Matter 94±23  97±26 91±20  99±27 89±19 97±27 93±18 
          
White Matter 20±6  20±7 19±4  18±5 18±5 22±7 20±5 
 
 
Table 9b. CBF (mL/100 g/min) ± SDs of all subjects for genders and age groups 
separately. No differences between subgroups were found. 
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           Gender       Age Groups   
ROIs   All   Males Females I II III IV  
GRAY MATTER          
Frontal 2.9±0.6  3.1±0.7 2.7±0.4 * 2.6±0.4 3.0±0.7 3.0±0.7 3.1±0.5 * 
           
Occipital 3.0±0.7  3.2±0.8 2.8±0.5 * 2.8±0.6 3.1±0.6 3.2±0.9 3.0±0.5  
           
Temporal 3.0±0.6  3.2±0.7 2.8±0.4 * 2.7±0.4 3.0±0.7 3.1±0.7 3.0±0.6  
           
Parietal 3.0±0.7  3.2±0.8 2.8±0.4 * 2.7±0.4 3.0±0.7 3.2±0.9 3.2±0.5 * 
WHITE MATTER          
Frontal 4.0±0.8  4.3±0.9 3.7±0.6 * 3.9±0.7 4.1±0.8 4.0±0.8 4.3±0.9  
           
Occipital 4.6±1.0  4.9±1.1 4.3±1.0 * 4.6±0.9 4.5±1.2 4.6±1.2 4.7±0.8  
           
Temporal 4.3±1.1  4.7±1.0 4.0±1.1 * 4.2±1.1 4.4±1.2 4.1±1.1 4.5±1.2  
           
Parietal 4.3±1.0  4.7±1.0 4.0±0.8 * 4.2±0.6 4.5±1.1 4.2±0.9 4.4±1.1  
DEEP GRAY MATTER         
Caudatus 2.8±0.6  3.0±0.7 2.6±0.5 * 2.5±0.5 2.7±0.7 2.9±0.9 3.0±0.6  
           
Thalamus 2.8±0.7  3.1±0.8 2.6±0.5 * 2.5±0.6 2.8±0.8 3.0±0.7 2.9±0.6  
MEAN VALUES          
Gray Matter 3.0±0.6  3.2±0.7 2.8±0.4 * 2.7±0.4 3.0±0.7 3.1±0.7 3.1±0.5  
           
White Matter 4.3±0.8  4.6±0.8 4.0±0.6 * 4.2±0.6 4.4±0.9 4.2±0.8 4.5±0.7  
 
 
Table 9c. MTT (seconds) ± SDs of all subjects for genders and age groups separately. 
Significant findings between subgroups have been marked with asterisks. 
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Figure 7a. CBV (mL/100 g) ± SDs of gray and white matter of the healthy brain in age 
groups I to IV and in males and females separately. Squares=gray matter and 
triangles=white matter. 
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Figure 7b. CBF (mL/100 g/min) ± SDs of gray and white matter of the healthy brain in 
age groups I to IV and in males and females separately. Squares=gray matter and 
triangles=white matter. 
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Figure 7c. MTT (seconds) ± SDs of gray and white matter of the healthy brain in age 
groups I to IV and in males and females separately. Squares=gray matter and 
triangles=white matter. 
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  Stenotic Side   Contralateral Side 
    ACS SCS   ACS SCS 
Gray Matter      
      Preoperative 4.6 (4.0-5.2) 4.6 (4.1-5.1)  4.6 (4.1-5.1) 4.6 (4.1-5.1) 
       
      Postoperative 4.5 (4.0-5.0) 4.7 (4.4-5.1)  4.3 (3.9-4.7) 5.0 (4.6-5.3) 
       
      Chronic 4.6 (4.2-5.0) 4.3 (3.8-4.8)  4.6 (4.2-5.1) 4.3 (3.9-4.6) 
White Matter      
      Preoperative 1.9 (1.6-2.2) 1.9 (1.6-2.1)  1.9 (1.6-2.1) 1.8 (1.6-2.0) 
       
      Postoperative 1.7 (1.5-1.9) 1.8 (1.5-2.1)  1.6 (1.4-1.8) 1.8 (1.5-2.1) 
       
      Chronic 1.7 (1.5-2.0) 1.6 (1.4-1.8)  1.7 (1.5-2.0) 1.7 (1.4-1.9) 
Watershed      
      Preoperative 2.0 (1.8-2.3) 1.9 (1.6-2.2)  2.0 (1.7-2.3) 1.9 (1.6-2.1) 
       
      Postoperative 1.8 (1.6-2.1) 1.8 (1.5-2.1)  1.8 (1.6-2.1) 1.8 (1.5-2.0) 
       
      Chronic 1.8 (1.5-2.0) 1.7 (1.4-1.9)   1.8 (1.6-2.1) 1.7 (1.4-2.0) 
 
Table 10a. CBV (mL/100 g) of CS patients (95% confidence interval) for ACS and SCS 
patient groups separately at three imaging stages. ACS=asymptomatic carotid stenosis, 
SCS=symptomatic carotid stenosis. 
 
 
 
CAROTID STENOSIS AND ENDARTERECTOMY 
 
In comparing ASC and SCS patient groups separately, the following was found. In SCS 
patients, the preoperative MTT was higher in the ipsilateral WM (p<0.001) and WsR 
(p<0.001), and marginally higher in the GM (p=0.05), in comparison with the 
contralateral hemisphere (Table 10c). In the postoperative value and in the ACS patient 
group, no differences were detected on the MTT (p>0.05). No interhemispheric 
differences in the CBV were detected at any stage and in any subgroup (p>0.05) (Table 
10a). In SCS patients, the preoperative CBF was lower in the ipsilateral WM (p<0.01) and 
WsR (p<0.01), and marginally lower in the GM (p=0.05). By contrast, in ACS patients, 
only the ipsilateral CBF of the GM was lower than in the contralateral hemisphere 
(p<0.05) (Table 10b). The interhemispheric ratio showed the abolition of asymmetry by
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  Stenotic Side   Contralateral Side 
    ACS SCS  ACS SCS 
Gray Matter      
      Preoperative 64 (61-68) 58 (54-63)  68 (64-72) 65 (61-68) 
       
      Postoperative 70 (66-74) 65 (61-69)  70 (67-74) 68 (63-73) 
       
      Chronic 69 (66-73) 65 (59-71)  69 (66-73) 66 (60-72) 
White Matter      
      Preoperative 22 (19-25) 19 (16-21)  23 (20-26) 22 (20-25) 
       
      Postoperative 24 (20-27) 20 (18-23)  24 (20-27) 22 (19-25) 
       
      Chronic 21 (20-23) 21 (17-25)  21 (18-24) 23 (19-26) 
Watershed      
      Preoperative 25 (22-29) 19 (16-22)  24 (21-28) 23 (19-26) 
       
      Postoperative 25 (22-29) 20 (17-23)  26 (22-30) 22 (18-25) 
       
      Chronic 22 (19-24) 22 (18-26)   22 (19-24) 23 (19-27) 
 
Table 10b. CBF (mL/100 g/min) of CS patients (95% confidence interval) for ACS and 
SCS patient groups separately at three imaging stages. ACS=asymptomatic carotid 
stenosis, SCS=symptomatic carotid stenosis.  
 
 
 
 
CEA. A slight trend for higher CBV in the contralateral hemisphere at the early 
postoperative stage is reflected in the interhemispheric ratio. In the WsR, no difference 
was seen between the anterior and posterior territories. 
In comparing SCS patients with ACS patients, the SCS patients displayed longer 
ipsilateral MTT before CEA, most pronounced in the WM and WsR, which improved in 
subsequent measurements, whereas the ACS patients’ hemodynamic improvement was 
only marginal or transient (Table 10a-c). SCS patients tended to have a slightly lower 
preoperative CBF. The CBV remained homogeneous between the groups. However, 
none of the perfusion parameters showed significant differences between ACS and SCS 
groups after correction for multiple correlations. 
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  Stenotic Side   Contralateral Side 
    ACS SCS  ACS SCS 
Gray Matter      
      Preoperative 4.3 (3.6-5.0) 4.8 (4.3-5.3)  4.1 (3.5-4.7) 4.2 (3.8-4.7) 
       
      Postoperative 3.9 (3.4-4.4) 4.4 (4.0-4.8)  3.8 (3.3-4.2) 4.4 (4.0-4.8) 
       
      Chronic 4.3 (3.8-4.8) 4.0 (3.6-4.4)  4.3 (3.7-4.8) 3.9 (3.6-4.2) 
White Matter      
      Preoperative 5.6 (4.9-6.2) 6.5 (5.7-7.2)  5.3 (4.6-5.9) 5.1 (4.6-5.5) 
       
      Postoperative 4.5 (4.0-5.0) 5.5 (4.9-6.1)  4.4 (3.9-4.8) 5.0 (4.6-5.5) 
       
      Chronic 5.2 (4.7-5.8) 4.8 (4.3-5.3)  5.2 (4.7-5.8) 4.6 (4.2-4.9) 
Watershed      
      Preoperative 5.4 (4.8-6.1) 6.7 (5.9-7.4)  5.1 (4.5-5.6) 5.2 (4.7-5.7) 
       
      Postoperative 4.5 (4.1-4.9) 5.6 (5.0-6.2)  4.4 (4.0-4.8) 5.0 (4.6-5.4) 
       
      Chronic 5.0 (4.5-5.5) 5.0 (4.5-5.5)  5.2 (4.7-5.7) 4.6 (4.2-4.9) 
 
Table 10c. MTT (seconds) of CS patients (95% confidence interval) for ACS and SCS 
patient groups separately at three imaging stages. ACS=asymptomatic carotid stenosis, 
SCS=symptomatic carotid stenosis. 
 
 
 
 
Fourteen patients had a visible perfusion deficit on the MTT map in the 
ipsilateral carotid territory (Figure 8). Twelve of these patients were symptomatic and 
only two asymptomatic (p<0.01). The ipsilateral MTT in the population with visualized 
hypoperfusion was in the WM 7.5 (6.7-8.3) seconds, in the WsR 7.2 (6.2-8.2) seconds, 
and in the GM 5.5 (4.9-6.2) seconds. The respective values for the population without a 
deficit were 5.4 (4.9-6.9, p<0.001) seconds, 5.5 (5.0-6.1, p<0.01) seconds, and 4.1 (3.7-
4.6, p<0.01) seconds. In the visually hypoperfused subjects, the interhemispheric MTT 
ratio was 1.46 (1.32-1.60) for the WM, 1.39 (1.21-1.56) for the WsR, and 1.28 (1.13-1.42) 
for the GM. In subjects without a visible perfusion deficit, the respective values were 1.06 
(1.01-1.11), 1.09 (1.04-1.15), and 1.02 (0.98-1.06) (p<0.001 for all comparisons). The 
patients with a visible deficit represented a higher grade of stenosis than those without,
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Figure 8. Preoperative MTT map of a 73-year-old male with a visible perfusion deficit. 
 
 
 
 
85 (81-90) % versus 76 (73-79) % (p<0.01). The lowest degree of stenosis with a visually 
detected perfusion deficit was 71% (two subjects). In the postoperative maps, no 
hypoperfusion was seen. 
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DISCUSSION 
 
 
 
DWI and DSC MRI at 1.5 T were used to study several brain regions of a healthy 
population, ischemic stroke patients, CS patients before and after CEA, and subjects with 
LA. Age- and gender-dependency, the effect of ischemia, CS, CEA, and LA on ADCav 
values and perfusion parameters were tested. The studies yielded some expected results as 
well as several novel findings. The findings in each subpopulation are discussed first, then 
criticism and limitations of the study, and finally, a summary and concluding remarks are 
presented. 
 
 
HEALTHY BRAIN 
 
While DWI and DSC MRI are widely used for diagnostic purposes, normal values for 
brain diffusion and perfusion parameters in a representative healthy population have not 
been available. Using DWI and DSC MRI, 80 healthy people aged 22 to 85 years were 
studied to establish quantitative ADCav values and perfusion parameters for several 
regions of the brain. The study population was homogeneous. As no reports of normal 
ADCav values and perfusion parameters for the brain in ethnically diverse populations 
could be found in the literature, our results cannot directly be extrapolated to people of 
different races. However, as macro- and microstructural properties of the human brain 
are identical in people of various races, the results are likely valid across ethnic 
populations. 
The ADCav values and perfusion parameters of the cortical GM were higher than 
those of the WM, being in good agreement with the results of previous studies (Chien et 
al, 1990; Gideon et al, 1994; Koshimoto et al, 1999; Vonken et al, 1999; Tanner et al, 
2000). The difference may partly be due to structural, functional, and circulation 
differences between the GM and the WM (Netter, 1991; Tatu et al, 1998), and partly to 
methodological issues. The GM contains more water and has a higher blood flow than 
the WM (de Groot and Chusid, 1991), both of which contribute to the ADCav values and 
perfusion parameters. Furthermore, a partial volume effect of the CSF and the major 
vessels of the meninges adjacent to the cortical GM may cause changes in these 
parameters (Latour and Warach, 2002). In the study of ADCav values (Study I), the very 
small variation within the cortical GM ROIs suggests that CSF contamination is unlikely. 
However, in the DSC MRI study (Study II), the range within the CBF of the GM was 
fairly large, indicating possible contamination of those ROIs with adjacent major vessels 
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of the meninges. The ADCav values of the CSF were more than twice as high as those of 
the GM and almost three times as high as those of the WM, since diffusion is much less 
restricted in the CSF than in brain tissue. In the basal ganglia and the thalamus, the 
ADCav values and perfusion parameters were between the values of the cortical GM and 
the WM, probably because of their microstructural properties and circulation (de Groot 
and Chusid, 1991; Tatu et al, 1998). 
The brain lobes showed small variability in perfusion parameters, supporting the 
findings of earlier reports (Catafau et al., 1996; Tanaka et al., 2000). Temporal lobes 
tended to have higher perfusion rates than the other three lobes. The ADCav values of 
the 45 healthy people in Study III also showed small lobular variability, the frontal lobes 
having the highest values. This finding was, however, not supported by the results for 80 
healthy people in Study I. This discrepancy may partly be due to the marginally different 
ROI analyses used (see below) or the slightly different subject populations concerning the 
amount and severity of LA. Generally, the differences between the brain lobes both in 
the DWI studies and in the DSC MRI study were small, and the clinical significance of 
these differences, if any, remains to be clarified in future studies. It may, however, be 
hypothesized that the lobular variability is partly due to differences in the microscopic 
structure and functional organization of the brain, and partly to the different vascular 
organization of the lobes (de Groot and Chusid, 1991; Tatu et al, 1998). The hypothesis 
of different vascular organization of the lobes receives some support from the findings of 
the WsR (Study III), since the anterior WsR showed higher ADCav values than the 
posterior one. 
DWI and DSC MRI did not demonstrate any differences between brain 
hemispheres regardless of whether the analyses were conducted between the right and 
left hemispheres or between dominant and nondominant sides. Only the ADCav values of 
the left cerebellar GM were higher than those of the right one, but the finding was almost 
negligible and could have been the result of contamination of the cerebellar GM ROIs 
with the WM or CSF, because the cerebellar GM is thin and has extensive folia. 
The absolute ADCav values and perfusion parameters found in the studies of the 
healthy population were in good correlation with those in the literature (Gideon et al, 
1994; Østergaard et al, 1996a; Schreiber et al, 1998; Koshimoto et al, 1999; Engelter et al, 
2000b; Tanner et al, 2000). However, despite the main results of the DSC MRI study 
being in agreement with earlier research, some differences were found in the CBF of the 
cortical GM (94±23 mL/100 g/min) and in the CBV of the WM (1.3±0.4 mL/100 g). 
Although within the upper range of the CBF reported in the literature (Naritomi et al, 
1979; Herzog et al, 1996; Schreiber et al, 1998), the CBF of the cortical GM was still 
relatively high, especially when compared with the lower boundary (Leenders et al, 1990; 
Koshimoto et al, 1999). This finding may be due to major vessel contamination, which 
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inherently increases CBF. The ROIs of the cortical GM are situated near the vessels of 
the meninges, and thus, contamination is difficult to eliminate altogether. The CBV of 
the WM, by contrast, was slightly lower than values reported previously (Schreiber et al, 
1998; Koshimoto et al, 1999). As data for the healthy population were collected with a 
SE-based sequence, the CBV may in fact represent the value for the microvasculature, 
which by definition is lower than the CBV obtained by GE-based sequences (Weisskoff 
et al, 1994; Boxerman et al, 1995). In addition, a clear difference in sample sizes between 
the DSC MRI study (n=80) and the studies of the literature (n=10-41) might account for 
this small difference in WM CBV. Since the above-mentioned deviations from the 
previous results were only marginal and the majority of the findings in Studies I and II 
were in excellent correlation with the literature, DSC MRI and especially DWI can be 
considered to be feasible methods in the study of cerebral hemodynamics and diffusional 
changes in healthy populations. 
Generally, the ADCav values and perfusion parameters did not change with age. 
However, a significant age-dependent increase was observed in the ADCav values of the 
thalami and the CSF of the lateral ventricles, as well as in the MTT of the frontal and 
parietal GM. Moreover, although not significant, a tendency for an increase was seen in 
mean GM values of the MTT and CBV. Whether the increase in the thalami was due to 
structural or functional changes related to aging or was a mere statistical artifact remains 
to be shown. However, some tendency toward an age-related ADCav increase of the 
thalami (Engelter et al, 2000b) and the whole brain area (Rovaris et al, 2003) have also 
been found previously, but no firm conclusions could be drawn. The diffusional increase 
in the CSF of the lateral ventricles may be due to the aging brain becoming less 
compliant, with the age-related enlargement of the ventricles allowing for more pulsative 
movement of the CSF (Bakshi et al, 2000). This pulsative movement is likely to increase 
the turbulence of the CSF flow (Sherman et al., 1987), resulting in an increase in diffusion 
(Bakshi et al, 2000; Chen et al, 2001). The GM MTT increase found was in line with 
earlier reports (Fujishima and Omae, 1980). It may be hypothesized that the small 
increase in these values reflects a decrease in cerebral perfusion pressure with age. The 
results of all of the other perfusion parameters have been highly variable in the literature 
(Marchal et al, 1992; Gideon et al, 1994; Engelter et al, 2000b; Meltzer et al, 2000; 
Wirestam et al, 2000; Chen et al, 2001), and therefore, no conclusions can be drawn. 
Although the search for gender-related differences in cerebral anatomy and 
physiology has been extensive, the findings of clinical and imaging methods have been 
highly variable (Jones et al., 1998; Gur et al, 1999). The findings of Studies I and II will 
not reduce the confusion. The ADCav values did not show any differences between 
genders. The marginal gender-related differences that were found in the MTT and CBV 
might be accounted for by differences in macro-to-microvascular hematocrit of males 
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and females. The generally higher blood volume in men than in women might be 
reflected in differences in MTT values. In addition, a possible effect due to the different 
sizes of men and women cannot be overlooked. However, the definitive reason for these 
small hemodynamic differences, if true, remains to be clarified in the future. 
In conclusion, the findings of the ADCav values and perfusion parameters in a 
healthy population showed that aging and gender themselves, without known diseases, 
have only minor effects on cerebral water diffusion and blood circulation. These findings 
are important for future studies comparing disease states with normal aging. 
 
 
ISCHEMIC STROKE 
 
The ADCav values of ten acute ischemic stroke patients without thrombolytic therapy 
from the hyperacute (less than six hours) to the chronic phase (three months) were 
studied as a comparison group for the subjects with LA (Study V). The results were in 
good correlation with the literature. In hyperacute to subacute stages (one week), the 
ADCav values were clearly lower (Warach et al, 1995; Lutsep et al, 1997; Ahlhelm et al, 
2002) than those of the normal-appearing WM and leukoaraiotic regions. The ischemic 
lesions at a one-month stage (Lutsep et al, 1997; Schlaug et al, 1997) and the regions of 
LA could not be distinguished from each other solely by analysis of their ADCav values. 
The ADCav values of the chronic ischemic stroke group, by contrast, were clearly higher 
(Lutsep et al, 1997; Ahlhelm et al, 2002) than those of the regions of LA, and thus, easy 
to distinguish from them. The follow-up studies of the ischemic stroke ADCav values 
were consistent with these findings (Marks et al, 1996; Schlaug et al, 1997; Weber et al, 
2000). It seems that DWI is useful in distinguishing ischemic stroke lesions of acute and 
chronic stages from regions of LA solely by means of ADCav values (Calli et al, 2003). As 
the ADCav values of one-month infarcts and the leukoaraiotic regions were similar, DWI 
appeared not to be useful in distinguishing LA from brain infarction at this time point. 
Here, conventional MR images are needed for the differential diagnosis. However, the 
use of conventional MR images is also recommended for more reliable differential 
diagnosis at other time points of ischemic stroke and LA. 
The absolute ADCav values may identify the boundaries of the ischemic tissue 
precisely (Dardzinski et al., 1993), but their reliable use requires normal reference values 
for each brain region. A considerable amount of experimental work has been devoted to 
distinguishing normal and ischemic pixels from each other based on ADCav values 
(Dardzinski et al, 1993; Takano et al., 1996; Takano et al., 1997). The quantitative values 
for normal and pathologic structures are especially important when focal or diffuse 
abnormalities are suspected because minor changes may be difficult to detect by visual 
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inspection. In experimental studies, the comparison of the ADCav values of the same 
pixels before and after ischemia induction, or the difference in the ADCav values of the 
infarcted and the intact hemisphere have been used to detect early ischemia-induced 
ADCav changes (Mintorovitch et al., 1991; Davis et al., 1994; Roussel et al., 1994; Li et al., 
1998). In humans, imaging before stroke insult is not feasible, and the use of the 
contralateral region for reference may have limitations due to possible earlier lesions. 
Therefore, ADCav values of the healthy population encompassing the entire brain are 
important as a normal value reference in the analysis of ischemic stroke patients as well as 
patients with other brain diseases. 
DWI is highly reliable and accurate in the diagnosis of hyperacute stroke (Fiebach 
et al, 2002). However, the combination of DWI with PI and MRA should be obtained 
outside the three-hour time-window if thrombolytic therapy is considered (Röther et al, 
2002; Schellinger et al, 2003). When a clear demarcation of the irreversibly damaged 
infarct core and the surrounding tissue-at-risk, i.e. the ischemic penumbra, is seen, 
thrombolytic therapy can be considered even after the three-hour time-window with 
acceptable safety. However, the finding of the visible perfusion deficit in a subgroup of 
CS patients (n=14) in Study IV should remind clinicians about possible chronic 
hypoperfusion underlying the diffusion-perfusion mismatch even in a patient with 
hyperacute ischemia. The benefit of thrombolytic therapy in such patients may be less 
than in patients without CS. 
In conclusion, DWI combined with PI and MRA is highly reliable in the 
diagnosis of hyperacute stroke and in aiding the decision-making for thrombolytic 
therapy after the three-hour time-window has elapsed. The ADCav values of ischemic 
stroke have a typical evolution from the hyperacute to the chronic stage. The reference 
values for human stroke studies must be obtained from a strictly healthy human 
population, as was the case here. 
 
 
CAROTID STENOSIS AND ENDARTERECTOMY 
 
DWI and DSC MRI were used to study the effect of CS and CEA on ADCav values and 
perfusion parameters in ACS and SCS patient groups separately. Forty-six unilateral CS 
patients were selected from the 102 CS patients included in the Helsinki Carotid 
Endarterectomy Study. 
In the SCS patient group, the preoperative ADCav values and MTT were clearly 
elevated, and the CBF decreased in the WM and WsR of the hemisphere ipsilateral to the 
CS. The clear hemispheric differences in the perfusion parameters were not detected in 
the ACS patient group, but the ipsilateral ADCav values were elevated in that patient 
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group as well. By contrast, the CBV did not differentiate the hemispheres in either of the 
subgroups. The most substantial change linked to the hemodynamic effect of the CS was 
found in the MTT, supporting previous findings (Maeda et al, 1999; Lythgoe et al, 2000). 
The hypoperfusion, sufficiently severe to be visually detected in over half of the SCS 
patients, was significantly associated with the symptomatic status of the stenosis. The 
threshold for the visual detection of the perfusion deficit could be approximated as an 
ipsilateral prolongation of the MTT of more than 15-20%. The high prevalence of the 
visible perfusion deficit in the SCS patient group is a reminder of the potentially 
confounding role of chronic hypoperfusion in patients with hyperacute ischemic stroke, 
as it may erroneously be attributed to the acute thrombosis and be regarded as tissue-at-
risk (Schlaug et al, 1999; Neumann-Haefelin et al, 2000b). In such cases, MRA 
demonstrating a tight CS without intracranial arterial occlusions should arouse suspicion 
of a chronic hypoperfusive state. 
CEA was followed by a rapid decrease of the ipsilateral ADCav values of the WM 
and WsR near the levels of the contralateral hemisphere. This interesting finding is 
discussed in detail in the next section (Leukoaraiosis, see below). The increased MTT and 
the decreased CBF in the ipsilateral hemisphere of SCS patients reached the levels of the 
contralateral hemisphere; the CBV remained at the preoperational level. In ACS patients, 
the only significant change was observed in the ADCav values of the WM and WsR, as 
described above. In the contralateral hemisphere, no postoperative changes were detected 
other than a slight MTT improvement. The chronic-stage (three months) perfusion 
parameters approached the baseline values, especially in ACS patients. This may explain 
the small long-term changes in cerebral hemodynamics, also detected previously 
(Kluytmans et al, 1998a; Wiart et al, 2000). 
The findings of the perfusion parameters did not support any particular 
hemodynamic vulnerability of the WsR or an asymmetrical impact on the anterior and 
posterior border zones (Wiart et al, 2000). The variation in the CBV was notably low. 
The CBV is not thought to be sensitive to delay and dispersion of the bolus (Calamante 
et al, 2000), and only small differences between the ACS and SCS patient groups were 
seen. Furthermore, the CBV is not likely to be the most sensitive indicator of the 
hemodynamic reserve. Completely deviating from the findings of the DSC MRI study, 
the ADCav values of the WsR showed clear differences between the anterior and 
posterior WsR. The anterior WsR had higher ADCav values than the posterior WsR at 
every time point. The finding was in good correlation with a previous DSC MRI study 
(Wiart et al, 2000), and with the finding of the highest ADCav levels in the WM of the 
frontal lobes. The CS in anterior circulation may be hypothesized to have a propensity to 
accentuate the differences between the lobes and WsR, depending on the degree of 
functioning collaterals from anterior or posterior circulation. Since the findings of the 
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DSC MRI study did not support the hemodynamic difference between the anterior and 
posterior WsR, no firm conclusions about this hypothesis can be drawn. 
The ADCav values and perfusion parameters of the cortical GM and the thalamus 
did not display interhemispheric or postoperative variation (Wiart et al, 2000). Apart from 
the microstructural differences between the GM and the WM, the better preservation of 
the ADCav levels and perfusion parameters in these structures can also be explained by 
differences in their blood flow. In addition to their arterial supply, the cortical GM 
receives leptomeningeal collateral supply, and the thalamus vertebrobasilar collateral 
supply (Tatu et al, 1996; 1998). The findings corroborate the greater hemodynamic 
impairment of the WM as compared with the GM (Kluytmans et al, 1998a). 
The ADCav variation occurred regardless of whether the patients’ stenoses were 
symptomatic or asymptomatic, whereas the subtle hemodynamic preoperative 
impairment seen in the perfusion parameters of the SCS patient group and its more 
pronounced response to CEA in comparison with the ACS patient group were elicited. 
Since the levels of the ADCav values of the ipsilateral hemispheres and their development 
after CEA were uniform in the ACS and SCS patient groups, also appearing 
homogeneous in terms of patient characteristics (age, risk factors, and degree of CS), the 
ADCav measurements did not distinguish the effect of CS in ACS and SCS patient 
groups. These measurements also did not shed light on why or by which mechanisms 
some patients with similar CS become symptomatic and some do not. 
In the contralateral hemisphere, no changes except for a small decrease in the 
MTT occurred after CEA. Still, it is notable that also the contralateral ADCav values were 
higher than in healthy controls. This underscores the pivotal difference between the 
patients and controls and reflects the greater propensity for leukoaraiotic changes in the 
presence of various risk factors for vascular disease. 
In conclusion, the results of the DSC MRI study (Study IV) corroborate that the 
preoperative hemodynamic adaptation seems to be poorer in SCS patients than in ACS 
patients. This may be revealed as an abnormal interhemispheric ratio of the MTT, often 
producing a visible perfusion deficit in higher-grade stenoses. The ACS patients 
represented a more stable hemodynamic constitution, and their long-term hemodynamic 
response to the CEA was negligible. The better hemodynamic adaptation may partly 
account for the lesser benefit from surgery in these patients, and could also, at least to 
some extent, explain why they are asymptomatic. Although not having a direct impact on 
the treatment of CS, the findings serve as a reminder not to overlook the hemodynamic 
concept in viewing the determinants for SCS, and they encourage future trials to take 
advantage of more functional and dynamic imaging methods for improved evaluation and 
risk assessment in carotid disease. The results of the DWI study (Study III), by contrast, 
showed that DWI alone could not distinguish ACS and SCS patients by the effects of CS 
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and CEA by means of the ADCav values, nor did it shed light on why or by which 
mechanisms some patients with similar CS become symptomatic and some do not. 
However, the findings of the interhemispheric differences in the ADCav values of the 
WM and WsR, and the diffusional changes after CEA raised the possibility of their 
involvement in the etiology and pathogenesis of LA (discussed in detail in the next 
section). 
 
 
LEUKOARAIOSIS 
 
DW images and conventional MR images were used to identify subjects with LA. The 85 
subjects were selected from the previously described populations of healthy subjects, the 
Helsinki Carotid Endarterectomy Study subjects, and acute ischemic stroke patients. A 
validated rating scale was used to classify the leukoaraiotic changes into several groups of 
different severity (Mäntylä et al, 1999a). Different imaging methods and MR sequences 
detect the lesions in various ways (Mäntylä et al, 1999a); on the ADCav maps, LA is seen 
as hyperintense lesions, which are bilateral, and as either patchy or diffuse changes in the 
cerebral WM (Okada et al, 1999). 
Although the etiology and pathogenesis of LA are manifold and somewhat 
controversial, chronic ischemia and hypoperfusion of the brain are the most popular 
hypotheses in recent literature (Oppenheimer et al, 1995; Pantoni and Garcia, 1997; 
Yamauchi et al, 1999; Markus et al, 2000; Brown et al, 2002; O'Sullivan et al, 2002; 
Hassan et al, 2003). The findings of Studies III and V seem to support these hypotheses 
since leukoaraiotic changes were found in all imaged stroke and almost all CS patients. As 
the rate of perfusion is estimated to constitute a few percentage points of the ADCav 
values of the brain tissue (Le Bihan et al, 1986), the expected consequence of a perfusion 
deficit in the CS patients would be a minor ipsilateral ADCav decrease. Interestingly, 
however, significantly higher ipsilateral ADCav values were found, indicating a more 
complex pathophysiology in these patients. Thus, it seems that it is not the short-term 
direct effect of reduced perfusion but the sequelae and other physiological mechanisms 
which dominate in the pathogenesis of LA (Rutgers et al., 2003). In experimentally 
induced chronic hypoperfusion, the WM has appeared to be the most vulnerable part of 
the brain, undergoing rarefaction with axonal and myelin changes (Kurumatani et al, 
1998). The small difference found between the hemispheres of the leukoaraiotic regions 
of ipsilateral CS patients gives some further support to the notion of a potentially 
irreversible leukoaraiogenesis, in accordance with a previous PET study (Yamauchi et al, 
1999). 
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Primarily elevated but potentially reversible ADCav values have been found to be 
associated with brain disease states that involve vasogenic edema such as hypertensive 
encephalography or eclampsia (Schwartz et al., 1998; Engelter et al., 2000a). Edematous 
change indicates altered permeability, redistribution of intra- and extracellular water, and 
overall increased water content of a tissue. According to the neuropathological 
investigations, one of the consequences of LA is axonal loss (Pantoni and Garcia, 1997), 
which may lead to an increase in the water content of a tissue, thereby increasing ADCav 
values and decreasing fractional anisotropy of the regions of LA (Jones et al, 1999). One 
may hypothesize that the finding of a relationship between severity of LA and increasing 
ADCav values reflects the extent of axonal loss. The partly reversible, preoperatively 
elevated ipsilateral ADCav values in the WM and WsR of CS patients suggest the 
concomitant existence of both reversible and irreversible components in the pathogenesis 
of LA, which is triggered and maintained by severe CS. The net decrease observed 
supports the hypothesis of a corrective effect on cellular-level mechanisms, one of which 
could be chronic, ipsilaterally focused relative ischemia. DWI provides information on 
the severity and extent of LA and detects areas of WM that are likely to undergo 
leukoaraiotic change over time, even though still appearing normal on conventional MRI. 
The findings of normal-appearing WM in subjects with LA and normal-appearing WM in 
the ipsilateral hemisphere of CS patients seem to represent a ‘preleukoaraiotic’ state, 
which is partly reversible with proper treatment. 
The classification of LA according to its severity and extent is a real challenge 
(Pantoni et al, 2002). Several rating scales with varying approaches have been designed. 
Some make a distinction between different regions, while others use an overall estimate 
of LA (Mäntylä et al, 1997; Scheltens et al, 1998; Pantoni et al, 2002). The scales often 
refer to definite pulse sequences or imaging methods (Mäntylä et al, 1999a). A previously 
validated rating scale developed at our hospital (Mäntylä et al, 1999a) was chosen for the 
studies presented here. LA was evaluated on conventional MR images, with 
periventricular and other WM regions being examined separately. The rating scale used 
has the advantage of taking into account the number, size, and shape of the leukoaraiotic 
lesions. Although the numerous rating scales have different approaches to evaluating the 
LA, comparison of the results of previous studies has been deemed to be reasonable 
(Pantoni et al, 2002). 
In conclusion, the severity of LA was directly related to the level of ADCav values, 
both in the lesions themselves and also in the normal-appearing WM. The same 
characteristic diffusional change with the preoperative elevation of the ADCav values in 
the ipsilateral WM and WsR was also detected in CS patients. This change was partly 
reversed after CEA. On the basis of these findings, the normal-appearing WM could be 
hypothesized to be associated with the early leukoaraiogenic process, which can partly be 
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reversed with proper management, in this case CEA. We coined the term 
‘preleukoaraiosis’ to define the WM regions that appear normal on conventional MR 
images but have increased ADCav values, and either undergo leukoaraiotic change over 
time or improve to normal or near normal following proper treatment, such as CEA in 
patients with severe CS. However, further long-term follow-up studies with repeated 
MRI are necessary to confirm this concept, to verify to what extent these affected WM 
regions truly undergo leukoaraiotic change, with or without intervention, and to elucidate 
the effect on and interplay with other determinants of WM degeneration. 
 
 
LIMITATIONS OF METHODS 
 
DIFFUSION-WEIGHTED IMAGING 
 
DWI methodology has rapidly developed during the last few years, and quantitative 
measurements of ADCav values have become feasible. However, the variability of the 
measurement protocols, imaging characteristics, and sequence characteristics (b values, 
diffusion time, gradient strength, TE, TR, cardiac gating) may still affect the ADCav 
values considerably (Sherman et al, 1987; Yoshiura et al, 2001; Wilson et al, 2002) and 
should be taken into account when comparing results between centers and studies. 
The ROI analysis of the ADCav maps has some limitations which should also be 
considered when comparing results between studies and centers. The ROIs should be 
sufficiently large to exclude the effect of small blood vessels on the ADCav values, yet 
small enough to eliminate the contamination risk of the given ROIs with nearby regions. 
The ROIs of cerebral lesions are reliable when the lesions, such as those of ischemic and 
severely leukoaraiotic regions, are easily detected on ADCav maps. The degree of 
uncertainty increases when the lesions are more diffuse and therefore hard to detect. 
Conventional MR images with equivalent slices should be collected to further increase 
reliability. The ROIs of the cortical GM contaminate easily with the CSF or the WM. In 
Studies I, III, and V, however, this contamination was nearly excluded, as the range of 
the ADCav values in the GM ROIs was fairly small, and the values were quite constant 
between studies. The ROIs of the WM are easier to analyze because the WM is wider and 
the contamination risk by other regions is less probable. However, the regions of LA, 
especially when they are abundantly present in a patchy fashion, are pitfalls for ROI 
analysis of the WM since they can increase ADCav values considerably. As mentioned 
before, the differences between Studies I and III in ADCav values of the WM of healthy 
subjects may partly be due to this methodological weakness, albeit the impact of a 
possible difference in LA between the groups cannot be wholly excluded. However, since 
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the control values in each study are analyzed separately, and in Study III blindedly to the 
values of the CS patients, the impact of this difference could be considered negligible, 
and the findings and comparisons reliable. 
Generally, DWI and quantitative analysis of ADCav maps can be deemed reliable 
so long as the pitfalls in ROI analysis and the methodological limitations are taken into 
account in comparisons of results. 
 
 
DYNAMIC SUSCEPTIBILITY CONTRAST IMAGING 
 
DSC MRI has not yet fulfilled the criteria for strict quantitation or accuracy, essentially 
because of the simplified assumptions made about the underlying microvascular structure 
(Kiselev, 2001; Calamante et al, 2002). This technique has some inherent limitations, 
which have been discussed in the Review of the Literature section. These limitations are 
briefly outlined here with conclusions followed by a discussion about the analyses of the 
perfusion maps and the ROIs. 
The quantitative analysis for absolute values of perfusion data is based entirely on 
determining an AIF, which cannot, however, be accurately ascertained by DSC MRI 
(Perthen et al, 2002). The shape of the AIF can be determined with rather good accuracy, 
but its height remains arbitrary (Østergaard et al, 1996b), and the proportionality factor 
relating MR signal change to concentration of Gd-DTPA is not equal in brain tissue and 
in larger vessels. Therefore, the size of the AIF has to be normalized to the injected dose 
of Gd-DTPA to produce quantitative results. The premises of the calculation may lead to 
a systematic error, although the values can be expected to be reasonably proportional to 
the actual blood flow. 
For the calculation of the absolute perfusion parameters, the microvascular 
hematocrit is approximated to be 2/3 of the systemic blood hematocrit (Østergaard et al, 
1996b); however, it is a more complex function of vessel size and physiological 
conditions, and therefore is more likely be subject-dependent. As the hematocrit ratio is 
directly associated with the scale factor of relating tissue first-pass area to the CBV, any 
errors in the hematocrit ratio are directly seen in the quantitative value of the CBV, and in 
other parameters afterwards. 
The orientation of MCA with respect to the main magnetic field has a major 
effect on the MR signal in PI. In imaging sessions, this is taken into account as accurately 
as possible, but the anatomy of the brain vessels is often different between subjects, thus 
having an impact on the perfusion parameters. 
A normalization factor for producing the absolute CBF by DSC MRI has been 
introduced which compares the MR CBF with the PET CBF among a small number of 
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normal subjects (Østergaard et al, 1998a; Østergaard et al, 1998b). However, the 
assumption that the same fraction of cardiac output reaches the brain in all subjects may 
not hold true with aging. The variation in the fraction of cardiac output reaching the 
brain is a potential confounding factor, especially in patients with heart failure, though 
not as likely in healthy subjects (Study II) or CS patients with cardiac diseases as exclusion 
criteria (Study IV). Partial refinement could become possible with correction algorithms 
(Lin et al, 2001). 
The results of Studies II and IV are characteristic for the sequences and 
parameters used. Deviations from the values may occur with different sequence and 
parameter combinations. The importance of imaging both controls and patients with the 
same sequence, the same imaging parameters, and the same MR equipment is even 
clearer than in studies with DWI. 
Because calculations of the perfusion maps rely almost entirely on the accuracy of 
the researcher, they are open to subjective errors. Inter- and intraobserver reliability was 
not, however, studied here. Completely automated software for measuring absolute 
perfusion parameters might be helpful for reliable quantitative calculations. 
The ROI analysis of the perfusion maps has difficulties since the ROIs are easily 
contaminated by other regions or major vessels, despite great care being taken. 
Conventional MR images are therefore critical in the analysis. Conventional MR images 
should be imaged with identical slices and be used as guides for ROI selection. In Studies 
II and IV, conventional MR images were used to identify the ROIs, but the drawing was 
done directly on CBF maps. The results of the ROIs from the WM, the WsR, and the 
thalamus can be considered to be reliable because they were easy to detect on the CBF 
maps. The ROIs of the cortical GM, by contrast, are difficult to detect and less reliable 
because of contamination risk with the major vessels of the meninges. 
In conclusion, while DSC MRI has some limitations, the data are fairly reliable 
when all steps of the analysis are carried out carefully. The methodology needs additional 
work for quantification and for more reliable use clinically, but in relative measures and in 
visual inspection, it already has its place in clinical settings. 
 
 
ROLE OF DIFFUSION-WEIGHTED AND DYNAMIC SUSCEPTIBILITY 
CONTRAST IMAGING IN CLINICAL DECISION-MAKING 
 
DWI is a feasible noninvasive method for acutely ill patients, as it takes only a few 
seconds to complete and has a complication risk of near zero as long as the normal 
exclusion criteria for MRI (Shellock et al, 1993) are taken into account. The DWI 
sequence is easy to add to other MRI modalities. 
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DWI is at its best in imaging the hyperacute stroke, for which conventional MR 
images and CT often give almost normal results. With the analysis of ADCav values, the 
regions of ischemic stroke at different phases, the leukoaraiotic regions, and the normal-
appearing WM can be differentiated from each other. As it detects areas of the normal-
appearing WM at risk for becoming leukoaraiotic, it can be considered to be a 
neuropathologic tool in vivo. 
Despite its limitations, the DSC MRI technique also has advantages over such 
imaging methods as PET, SPECT, and functional CT. It offers a good spatial and 
temporal resolution, is easy and fairly fast to complete, does not expose subjects to 
ionizing radiation, covers a large spatial volume with good structural images, and is widely 
available. Unfortunately, DSC MRI is not entirely noninvasive, as it demands intravenous 
contrast medium, thereby having a small risk of allergic reactions. 
On the raw images of DSC MRI, the hyperacute stroke lesion remains bright, 
while other healthy-appearing regions lose their brightness during the passage of the 
contrast agent bolus through the brain. Combining the DWI and DSC MRI, the 
diagnosis of hyperacute stroke becomes increasingly accurate. The most important phase 
of stroke imaging for optimal decision-making regarding management, particularly 
thrombolytic therapy, is during the early post-stroke hours (Schellinger et al, 2003). 
Age- and gender-matched controls are important in interpreting the results for 
any disease. The results of these studies showed no clinically significant changes with 
aging or gender, which is an important novel observation, although it requires 
confirmation by other studies. The most reliable data are yielded when both patients and 
controls are imaged with the same MR equipment and the same imaging parameters. In 
DSC MRI, this is even more important. 
In conclusion, DWI and DSC MRI have become widely used MRI sequences in 
several clinical settings. Their use is fairly easy and they provide valuable information not 
available from conventional MRI. However, the analysis of quantitative ADCav values or 
perfusion parameters requires expertise and accuracy. 
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CONCLUSIONS 
 
 
 
DWI and DSC MRI were used to study several brain regions of a large, representative 
healthy population with equal numbers of both genders and a wide age range. The other 
populations comprised ischemic stroke patients imaged from hyperacute to chronic stage 
of stroke, CS patients before and at three and 100 days after CEA, and subjects with LA. 
Age-, gender-, and hemisphere-dependency, and the effect of ischemia, CS, CEA, and LA 
on ADCav values and perfusion parameters (CBV, CBF, and MTT) were tested. Based on 
these results, the following conclusions were drawn: 
 
1. The ADCav values, CBV, CBF, and MTT in selected regions of the healthy human 
brain did not differ with age, gender, or brain hemisphere. An age-related change was, 
however, detected in the ADCav values of the lateral ventricles and the thalamus, and on 
the MTT of the cortical GM, supporting findings of previous studies. Small differences 
between genders on the CBV and MTT were detected in some brain regions, but their 
clinical significance was viewed as negligible and received no firm support from the 
literature. Diffusion and perfusion parameters between brain hemispheres of the healthy 
population were very similar. The parameters used in Studies I and II establish a wide 
reference base for clinical settings and future studies, but the limitations of the methods 
should be considered. 
 
2. The ADCav values, CBF, and MTT were different between the brain hemispheres of 
SCS patients before CEA. In ACS patients, only a difference between hemispheric 
ADCav values was detected. No hemispheric differences in either patient group were 
found after CEA. Although the perfusion patterns over time differed between ACS and 
SCS patient groups, no such differences were observed in the ADCav values. 
 
3. The ADCav values of the leukoaraiotic regions and the severity of LA were significantly 
correlated with each other; the more severe the LA, the higher the ADCav values of the 
lesions. The ADCav values could be used to distinguish leukoaraiotic regions from 
normal-appearing WM and from ischemic strokes at various stages, except in the 
ischemic stroke at one month. The ADCav values of the normal-appearing WM were also 
pathological and correlated with the severity of LA. DWI can be considered to be a tool 
for neuropathological investigations in vivo, as it detects areas of WM which may 
progress to LA, despite appearing normal on conventional images. However, such a 
process can only be verified in prospective follow-up studies. Additionally, the changes in 
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the normal-appearing WM seemed to be partly reversible, as indicated by the changes in 
the ADCav values on the ipsilateral hemisphere of CS after CEA. The concept of 
‘preleukoaraiosis with a partly reversible component’ was introduced to describe such 
changes. 
 
In conclusion, DWI and DSC MRI have become widely used MRI sequences in several 
clinical settings since they are fairly easy to use and they provide supplementory 
information to the conventional MRI. However, the analysis of ADCav values or 
perfusion parameters requires expertise and accuracy, and additional work for strict 
quantification is required. 
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